Publications

2023

  1. Sise ME, Katz-Agranov N, Strohbehn IA, Harden D, Moreno D, Durbin C, Toribio M, Neilan TG, Zanni MV. Use and Side Effects of Sodium Glucose Transporter 2 Inhibitors among U.S. People with HIV with Clinical Indications. J Acquir Immune Defic Syndr. 2023 May 24. doi: 10.1097/QAI.0000000000003227. Epub ahead of print. PMID: 37229530.
  2. Gupta S, Motwani SS, Seitter RH, Wang W, Mu Y, Chute DF, Sise ME, Glazer DI, Rosner BA, Curhan GC. Development and Validation of a Risk Model for Predicting Contrast-Associated Acute Kidney Injury in Patients With Cancer: Evaluation in Over 46,000 CT Scans. AJR Am J Roentgenol. 2023 May 17. doi: 10.2214/AJR.23.29139. Epub ahead of print. PMID: 37195792.
  3. Tang M, Kalim S. Response to Comment on Tang et al. The Impact of Carbamylation and Anemia on HbA1c’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130-137. Diabetes Care. 2023 May 1;46(5):e116. doi: 10.2337/dci23-0011. PMID: 37185690; PMCID: PMC10154661.
  4. Wen W, Portales-Castillo I, Seethapathy R, Durant O, Mengesha B, Krinsky S, Kroshinsky D, Kalim S, Goverman J, Nazarian RM, Chitalia V, Malhotra R, Kramann R, Malhotra CK, Nigwekar SU. Intravenous Sodium Thiosulphate for Calciphylaxis of Chronic Kidney Disease: A Systematic Review and Meta-analysis. JAMA Netw Open. 2023 Apr 3;6(4):e2310068. doi: 10.1001/jamanetworkopen.2023.10068. PMID: 37099293; PMCID: PMC10134003.
  5. Gupta S, Hanna PE, Ouyang T, Yamada KS, Sawtell R, Wang Q, Katz-Agranov N, Feghali L, Krasner CN, Bouberhan S, Castro CM, Sise ME. Kidney Function in Patients with Ovarian Cancer Treated with Poly (ADP-ribose) polymerase (PARP) Inhibitors. J Natl Cancer Inst. 2023 Apr 19:djad070. doi: 10.1093/jnci/djad070. Epub ahead of print. PMID: 37074956.
  6. Vergara-Cadavid J, Johnson PC, Kim HT, Yi A, Sise ME, Leaf DE, Hanna PE, Ho VT, Cutler CS, Antin JH, Gooptu M, Kelkar AH, Wells SL, Nikiforow S, Koreth J, Romee R, Soiffer RJ, Shapiro RM, Gupta S. Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation. Transplant Cell Ther. 2023 Apr 2:S2666-6367(23)01206-X. doi: 10.1016/j.jtct.2023.03.029. Epub ahead of print. PMID: 37015320.
  7. Cho WJ, Harden D, Moreno D, Dinulos JE, Hanna PE, Wang Q, Kim AY, Sise ME. Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failure. Nephrol Dial Transplant. 2023 Mar 22:gfad058. doi: 10.1093/ndt/gfad058. Epub ahead of print. PMID: 36948600.
  8. Patidar KR, Naved MA, Kabir S, Grama A, Allegretti AS, Cullaro G, Asrani SK, Worden A, Desai AP, Ghabril MS, Nephew LD, Orman ES. Longer time to recovery from acute kidney injury is associated with major adverse kidney events in patients with cirrhosis. Aliment Pharmacol Ther. 2023 Jun;57(12):1397-1406. doi: 10.1111/apt.17457. Epub 2023 Mar 7. PMID: 36883210.
  9. Portales-Castillo I, Rieg T, Khalid SB, Nigwekar SU, Neyra JA. Physiopathology of Phosphate Disorders. Adv Kidney Dis Health. 2023 Mar;30(2):177-188. doi: 10.1053/j.akdh.2022.12.011. PMID: 36868732.
  10. Seethapathy R, Wang Q, Zhao S, Strohbehn IA, Long JD, Dinulos JE, Harden D, Kadiyala VB, Moreno D, Sise ME. Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function. PLoS One. 2023 Feb 27;18(2):e0279765. doi: 10.1371/journal.pone.0279765. PMID: 36848366; PMCID: PMC9970064.
  11. Tiu BC, Strohbehn IA, Zhao S, Ouyang T, Hanna P, Wang Q, Gupta S, Leaf DE, Reynolds KL, Sise ME. Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study. Oncologist. 2023 Jun 2;28(6):e379-e390. doi: 10.1093/oncolo/oyad001. PMID: 36821637; PMCID: PMC10243781.
  12. Worden A, Pike F, Allegretti AS, Kaur H, Peng JL, Kettler CD, Orman ES, Desai AP, Nephew LD, Ghabril MS, Patidar KR. The prognostic impact of acute kidney injury recovery patterns in critically ill patients with cirrhosis. Liver Transpl. 2023 Mar 1;29(3):246-258. doi: 10.1097/LVT.0000000000000008. Epub 2023 Feb 17. PMID: 36811876; PMCID: PMC10068809.
  13. Murakami N, Hayden R, Hills T, Al-Samkari H, Casey J, Del Sorbo L, Lawler PR, Sise M, Leaf DE. Reply to ‘Use of convalescent plasma in the treatment of COVID-19’. Nat Rev Nephrol. 2023 Apr;19(4):272. doi: 10.1038/s41581-023-00691-3. PMID: 36806371; PMCID: PMC9937737.
  14. Patidar KR, Piano S, Cullaro G, Belcher JM, Allegretti AS; HRS-Harmony Consortia. Recent Advances in the Management of Hepatorenal Syndrome: A US Perspective. Clin Gastroenterol Hepatol. 2023 Apr;21(4):897-901.e1. doi: 10.1016/j.cgh.2022.12.034. Epub 2023 Feb 18. PMID: 36801201; PMCID: PMC10038893.
  15. Velez JCQ, Karakala N, Tayebi K, Wickman TJ, Mohamed MMB, Kovacic RA, Therapondos G, Kanduri SR, Allegretti AS, Belcher JM, Regner KR, Wentowski C. Responsiveness to Vasoconstrictor Therapy in Hepatorenal Syndrome Type 1. Kidney360. 2023 Apr 1;4(4):e448-e456. doi: 10.34067/KID.0000000000000068. Epub 2023 Feb 10. PMID: 36763632.
  16. Kalim S, Zhao S, Tang M, Rhee EP, Allegretti AS, Nigwekar S, Karumanchi SA, Lash JP, Berg AH. Protein Carbamylation and the Risk of ESKD in Patients with CKD. J Am Soc Nephrol. 2023 May 1;34(5):876-885. doi: 10.1681/ASN.0000000000000078. Epub 2023 Jan 21. PMID: 36757153.
  17. Kim MH, Sise ME, Xu M, Goldberg DS, Fontana RJ, Kort JJ, Alloway RR, Durand CM, Brown RS Jr, Levitsky J, Gustafson JL, Reese PP, Chung RT. Early initiation of glecaprevir/pibrentasvir after transplantation of HCV-viremic kidneys into HCV-negative recipients is associated with normalization in the altered inflammatory milieu. Clin Transplant. 2023 Apr;37(4):e14926. doi: 10.1111/ctr.14926. Epub 2023 Feb 17. PMID: 36752566.
  18. Murakami N, Hayden R, Hills T, Al-Samkari H, Casey J, Del Sorbo L, Lawler PR, Sise ME, Leaf DE. Author Correction: Therapeutic advances in COVID-19. Nat Rev Nephrol. 2023 Apr;19(4):273. doi: 10.1038/s41581-023-00686-0. Erratum for: Nat Rev Nephrol. 2023 Jan;19(1):38-52. PMID: 36747084; PMCID: PMC9901371.
  19. Wen W, Krinsky S, Kroshinsky D, Durant O, He J, Seethapathy R, Hillien SAS, Mengesha B, Malhotra R, Chitalia V, Nazarian RM, Goverman J, Lyons KS, Nigwekar SU. Patient-Reported and Clinical Outcomes Among Patients With Calciphylaxis. Mayo Clin Proc Innov Qual Outcomes. 2023 Jan 24;7(1):81-92. doi: 10.1016/j.mayocpiqo.2022.12.006. PMID: 36712824; PMCID: PMC9880339.
  20. Hanna PE, Wang Q, Strohbehn I, Moreno D, Harden D, Ouyang T, Katz-Agranov N, Seethapathy H, Reynolds KL, Gupta S, Leaf DE, Sise ME. Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR. medRxiv [Preprint]. 2023 Jan 18:2023.01.18.23284656. doi: 10.1101/2023.01.18.23284656. PMID: 36711583; PMCID: PMC9882433.
  21. Sise ME, Wang Q, Seethapathy H, Moreno D, Harden D, Smith RN, Rosales IA, Colvin RB, Chute S, Cornell LD, Herrmann SM, Fadden R, Sullivan RJ, Yang NJ, Barmettler S, Wells S, Gupta S, Villani AC, Reynolds KL, Farmer J. Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis. J Immunother Cancer. 2023 Jan;11(1):e006222. doi: 10.1136/jitc-2022-006222. PMID: 36657813; PMCID: PMC9853261.
  22. Wulczyn KE, Rhee EP, Myint L, Kalim S, Shafi T. Incidence and Risk Factors for Pruritus in Patients with Nondialysis CKD. Clin J Am Soc Nephrol. 2023 Feb 1;18(2):193-203. doi: 10.2215/CJN.09480822. Epub 2023 Jan 2. PMID: 36517248.
  23. Sutton NR, Malhotra R, St Hilaire C, Aikawa E, Blumenthal RS, Gackenbach G, Goyal P, Johnson A, Nigwekar SU, Shanahan CM, Towler DA, Wolford BN, Chen Y. Molecular Mechanisms of Vascular Health: Insights From Vascular Aging and Calcification. Arterioscler Thromb Vasc Biol. 2023 Jan;43(1):15-29. doi: 10.1161/ATVBAHA.122.317332. Epub 2022 Nov 22. PMID: 36412195; PMCID: PMC9793888.
  24. Tang M, Berg A, Rhee EP, Allegretti AS, Nigwekar S, Karumanchi SA, Lash JP, Kalim S. The Impact of Carbamylation and Anemia on HbA1c’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care. 2023 Jan 1;46(1):130-137. doi: 10.2337/dc22-1399. PMID: 36399777; PMCID: PMC9797644.
  25. Murakami N, Hayden R, Hills T, Al-Samkari H, Casey J, Del Sorbo L, Lawler PR, Sise ME, Leaf DE. Therapeutic advances in COVID-19. Nat Rev Nephrol. 2023 Jan;19(1):38-52. doi: 10.1038/s41581-022-00642-4. Epub 2022 Oct 17. Erratum in: Nat Rev Nephrol. 2023 Feb 6;: PMID: 36253508; PMCID: PMC9574806.
  26. Allegretti AS. NGAL in AKI and cirrhosis-Ready for prime time? Hepatology. 2023 May 1;77(5):1472-1474. doi: 10.1002/hep.32807. Epub 2023 Apr 17. PMID: 36169601; PMCID: PMC10043041.
  27. Wen W, Portales-Castillo I, Seethapathy R, Krinsky S, Kroshinsky D, Kalim S, Goverman J, Nazarian RM, Chitalia V, Malhotra R, Kramann R, Malhotra CK, Nigwekar SU. Intravenous sodium thiosulphate for vascular calcification of hemodialysis patients-a systematic review and meta-analysis. Nephrol Dial Transplant. 2023 Feb 28;38(3):733-745. doi: 10.1093/ndt/gfac171. PMID: 35521751; PMCID: PMC10111152.

2022

  1. Wang Q, Strohbehn IA, Zhao S, Seethapathy H, Strohbehn SD, Hanna P, Lee M, Fadden R, Sullivan RJ, Boland GM, Reynolds KL, Sise ME. Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma. Kidney Int Rep. 2022 Sep 8;7(11):2517-2521. doi: 10.1016/j.ekir.2022.08.030. PMID: 36531890; PMCID: PMC9751690.
  2. Martin P, Awan AA, Berenguer MC, Bruchfeld A, Fabrizi F, Goldberg DS, Jia J, Kamar N, Mohamed R, Pessôa MG, Pol S, Sise ME, Balk EM, Gordon CE, Adam G, Cheung M, Earley A, Jadoul M. Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int. 2022 Dec;102(6):1228-1237. doi: 10.1016/j.kint.2022.07.012. PMID: 36411019.
  3. Murakami N, Hayden R, Hills T, Al-Samkari H, Casey J, Del Sorbo L, Lawler PR, Sise ME, Leaf DE. Therapeutic advances in COVID-19. Nat Rev Nephrol. 2023 Jan;19(1):38-52. doi: 10.1038/s41581-022-00642-4. Epub 2022 Oct 17. PMID: 36253508; PMCID: PMC9574806.
  4. Halim A, Burney HN, Li X, Li Y, Tomkins C, Siedlecki AM, Lu TS, Kalim S, Thadhani R, Moe S, Ting SMS, Zehnder D, Hiemstra TF, Lim K. FGF23 and Cardiovascular Structure and Function in Advanced Chronic Kidney Disease. Kidney360. 2022 Jul 5;3(9):1529-1541. doi: 10.34067/KID.0002192022. PMID: 36245643; PMCID: PMC9528374.
  5. Gupta S, Garcia-Carro C, Prosek JM, Glezerman I, Herrmann SM, Garcia P, Abudayyeh A, Lumlertgul N, Malik AB, Loew S, Beckerman P, Renaghan AD, Carlos CA, Rashidi A, Mithani Z, Deshpande P, Rangarajan S, Shah CV, Seigneux S, Campedel L, Kitchlu A, Shin DS, Coppock G, Ortiz-Melo DI, Sprangers B, Aggarwal V, Benesova K, Wanchoo R, Murakami N, Cortazar FB, Reynolds KL, Sise ME, Soler MJ, Leaf DE; ICPi-AKI Consortium Investigators. Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI. J Immunother Cancer. 2022 Sep;10(9):e005646. doi: 10.1136/jitc-2022-005646. PMID: 36137651; PMCID: PMC9511654.
  6. Cucka B, Biglione B, Ko L, Nguyen ED, Khoury CC, Nigwekar SU, Robinson MK, Kroshinsky D. Calciphylaxis arising following bariatric surgery: A case series. JAAD Case Rep. 2022 Aug 5;28:4-7. doi: 10.1016/j.jdcr.2022.07.031. PMID: 36090194; PMCID: PMC9450058.
  7. Wen D, Zheng Z, Surapaneni A, Yu B, Zhou L, Zhou W, Xie D, Shou H, Avila- Pacheco J, Kalim S, He J, Hsu CY, Parsa A, Rao P, Sondheimer J, Townsend R, Waikar SS, Rebholz CM, Denburg MR, Kimmel PL, Vasan RS, Clish CB, Coresh J, Feldman HI, Grams ME, Rhee EP; CKD Biomarkers Consortium and CRIC Study Investigators. Metabolite profiling of CKD progression in the chronic renal insufficiency cohort study. JCI Insight. 2022 Oct 24;7(20):e161696. doi: 10.1172/jci.insight.161696. PMID: 36048534; PMCID: PMC9714776.
  8. Gupta S, Strohbehn IA, Wang Q, Hanna PE, Seethapathy R, Prosek JM, Herrmann SM, Abudayyeh A, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, de Seigneux S, Campedel L, Kitchlu A, Shin DS, Coppock G, Lumlertgul N, Garcia P, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Benesova K, Jhaveri KD, Cortazar FB, Weins A, Zuo Y, Mooradian MJ, Reynolds KL, Leaf DE, Sise ME; ICPi-AKI Consortium. Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer. Kidney Int. 2022 Oct;102(4):930-935. doi: 10.1016/j.kint.2022.07.019. Epub 2022 Aug 11. PMID: 35964800; PMCID: PMC9523226.
  9. Hanna P, Strohbehn I, Moreno D, Harden D, Seethapathy H, Gupta S, Lee M, Ouyang T, Frigault M, Sise ME. Comparison of short- and long-term adverse kidney outcomes after chimeric antigen receptor T cell therapy and autologous hematopoietic stem cell transplant for diffuse large B cell lymphoma. Bone Marrow Transplant. 2022 Oct;57(10):1623-1625. doi: 10.1038/s41409-022-01767-7. Epub 2022 Aug 3. PMID: 35922564.
  10. Wang Q, Moledina DG, Sise ME. Immune checkpoint inhibitors and kidney disease. Curr Opin Nephrol Hypertens. 2022 Sep 1;31(5):449-455. doi: 10.1097/MNH.0000000000000805. Epub 2022 Jul 11. PMID: 35894279.
  11. Allegretti AS, Subramanian RM, Francoz C, Olson JC, Cárdenas A. Respiratory events with terlipressin and albumin in hepatorenal syndrome: A review and clinical guidance. Liver Int. 2022 Oct;42(10):2124-2130. doi: 10.1111/liv.15367. Epub 2022 Aug 3. PMID: 35838488; PMCID: PMC9762017.
  12. Tang M, Kalim S. Novel Approaches for the Removal of Uremic Solutes. Clin J Am Soc Nephrol. 2022 Aug;17(8):1113-1115. doi: 10.2215/CJN.06860622. Epub 2022 Jul 14. PMID: 35835517; PMCID: PMC9435973.
  13. Chewcharat A, Chewcharat P, Liu W, Cellini J, Phipps EA, Melendez Young JA, Nigwekar SU. The effect of levocarnitine supplementation on dialysis-related hypotension: A systematic review, meta-analysis, and trial sequential analysis. PLoS One. 2022 Jul 14;17(7):e0271307. doi: 10.1371/journal.pone.0271307. PMID: 35834513; PMCID: PMC9282471.
  14. Gudsoorkar P, Jhaveri KD, Sise ME. Onconephrology: The Growth of Cancer- Kidney Connection, Part 2. Adv Chronic Kidney Dis. 2022 Mar;29(2):83-85. doi: 10.1053/j.ackd.2022.05.001. PMID: 35817529.
  15. Tiu BC, Zubiri L, Iheke J, Pahalyants V, Theodosakis N, Ugwu-Dike P, Seo J, Tang K, Sise ME, Sullivan R, Naidoo J, Mooradian MJ, Semenov YR, Reynolds KL. Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study. J Immunother Cancer. 2022 Jun;10(6):e004670. doi: 10.1136/jitc-2022-004670. PMID: 35705313; PMCID: PMC9204442.
  16. Hanna P, Strohbehn I, Wang Q, Frigault M, Sise ME. Acute kidney injury caused by haplostorm after allogenic hematopoietic stem cell transplant. Bone Marrow Transplant. 2022 Sep;57(9):1442-1444. doi: 10.1038/s41409-022-01720-8. Epub 2022 Jun 4. PMID: 35661834.
  17. Allegretti AS, Belcher JM. Bile Acids Are Important Contributors to AKI Associated with Liver Disease: CON. Kidney360. 2021 May 4;3(1):21-24. doi: 10.34067/KID.0006512020. PMID: 35378020; PMCID: PMC8967622.
  18. Patel ZM, Holbrook EH, Turner JH, Adappa ND, Albers MW, Altundag A, Appenzeller S, Costanzo RM, Croy I, Davis GE, Dehgani-Mobaraki P, Doty RL, Duffy VB, Goldstein BJ, Gudis DA, Haehner A, Higgins TS, Hopkins C, Huart C, Hummel T, Jitaroon K, Kern RC, Khanwalkar AR, Kobayashi M, Kondo K, Lane AP, Lechner M, Leopold DA, Levy JM, Marmura MJ, Mclelland L, Miwa T, Moberg PJ, Mueller CA, Nigwekar SU, O’Brien EK, Paunescu TG, Pellegrino R, Philpott C, Pinto JM, Reiter ER, Roalf DR, Rowan NR, Schlosser RJ, Schwob J, Seiden AM, Smith TL, Soler ZM, Sowerby L, Tan BK, Thamboo A, Wrobel B, Yan CH. International consensus statement on allergy and rhinology: Olfaction. Int Forum Allergy Rhinol. 2022 Apr;12(4):327-680. doi: 10.1002/alr.22929. PMID: 35373533.
  19. Seethapathy R, Zhao S, Long JD, Strohbehn IA, Sise ME. A Propensity Score- Matched Observational Study of Remdesivir in Patients with COVID-19 and Severe Kidney Disease. Kidney360. 2021 Dec 3;3(2):269-278. doi: 10.34067/KID.0006152021. PMID: 35373125; PMCID: PMC8967642.
  20. Wulczyn KE, Zhao SH, Rhee EP, Kalim S, Shafi T. Trajectories of Uremic Symptom Severity and Kidney Function in Patients with Chronic Kidney Disease. Clin J Am Soc Nephrol. 2022 Apr;17(4):496-506. doi: 10.2215/CJN.13010921. Epub 2022 Mar 4. PMID: 35246460; PMCID: PMC8993474.
  21. Sulkowski M, Telep LE, Colombo M, Durand F, Reddy KR, Lawitz E, Bourlière M, Cheinquer N, Scherbakovsky S, Ni L, Force L, Ramroth H, Gaggar A, Chokkalingam AP, Sise ME. Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment. Aliment Pharmacol Ther. 2022 May;55(9):1169-1178. doi: 10.1111/apt.16830. Epub 2022 Mar 2. PMID: 35235245; PMCID: PMC9313579.
  22. Tang M, Kalim S. Avenues for post-translational protein modification prevention and therapy. Mol Aspects Med. 2022 Aug;86:101083. doi: 10.1016/j.mam.2022.101083. Epub 2022 Feb 25. PMID: 35227517; PMCID: PMC9378364.
  23. Portales-Castillo I, Mount DB, Nigwekar SU, Yu EW, Rennke HG, Gupta S. Zoledronic Acid-Associated Fanconi Syndrome in Patients With Cancer. Am J Kidney Dis. 2022 Oct;80(4):555-559. doi: 10.1053/j.ajkd.2021.12.015. Epub 2022 Feb 24. PMID: 35219759; PMCID: PMC9399306.
  24. Halim A, Narayanan G, Hato T, Ho L, Wan D, Siedlecki AM, Rhee EP, Allegretti AS, Nigwekar SU, Zehnder D, Hiemstra TF, Bonventre JV, Charytan DM, Kalim S, Thadhani R, Lu T, Lim K. Myocardial Cytoskeletal Adaptations in Advanced Kidney Disease. J Am Heart Assoc. 2022 Mar;11(5):e022991. doi: 10.1161/JAHA.121.022991. Epub 2022 Feb 18. PMID: 35179046; PMCID: PMC9075094.
  25. Sise ME, Goldberg DS, Schaubel DE, Fontana RJ, Kort JJ, Alloway RR, Durand CM, Blumberg EA, Woodle ES, Sherman KE, Brown RS Jr, Friedewald JJ, Desai NM, Sultan ST, Levitsky J, Lee MD, Strohbehn IA, Landis JR, Fernando M, Gustafson JL, Chung RT, Reese PP. One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial. Kidney Int Rep. 2021 Dec 1;7(2):241-250. doi: 10.1016/j.ekir.2021.11.022. PMID: 35155863; PMCID: PMC8820987.
  26. Chewcharat A, Phipps EA, Bhatia K, Kalim S, Allegretti AS, Sise ME, Păunescu TG, Seethapathy R, Nigwekar SU. The association between olfactory and gustatory dysfunction and chronic kidney disease. BMC Nephrol. 2022 Jan 18;23(1):36. doi: 10.1186/s12882-021-02659-6. PMID: 35042465; PMCID: PMC8767746.
  27. Sinha S, Gould LJ, Nigwekar SU, Serena TE, Brandenburg V, Moe SM, Aronoff G, Chatoth DK, Hymes JL, Miller S, Padgett C, Carroll KJ, Perelló J, Gold A, Chertow GM. The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis. Clin Kidney J. 2021 Jul 6;15(1):136-144. doi: 10.1093/ckj/sfab117. PMID: 35035944; PMCID: PMC8757410.
  28. Long JD, Strohbehn I, Sawtell R, Bhattacharyya R, Sise ME. COVID-19 Survival and its impact on chronic kidney disease. Transl Res. 2022 Mar;241:70-82. doi: 10.1016/j.trsl.2021.11.003. Epub 2021 Nov 10. PMID: 34774843; PMCID: PMC8579714.
  29. Molnar MZ, Potluri VS, Schaubel DE, Sise ME, Concepcion BP, Forbes RC, Blumberg E, Bloom RD, Shaffer D, Chung RT, Strohbehn IA, Elias N, Azhar A, Shah M, Sawinski D, Binari LA, Talwar M, Balaraman V, Bhalla A, Eason JD, Besharatian B, Trofe-Clark J, Goldberg DS, Reese PP. Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation. Am J Transplant. 2022 Feb;22(2):599-609. doi: 10.1111/ajt.16834. Epub 2021 Oct 6. PMID: 34613666; PMCID: PMC8968853.
  30. Belcher JM, Parada XV, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Sharma P, Regner KR, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT, Allegretti AS; HRS-HARMONY Study Investigators. Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward. Am J Kidney Dis. 2022 May;79(5):737-745. doi: 10.1053/j.ajkd.2021.08.016. Epub 2021 Oct 2. PMID: 34606933.
  31. Boike JR, Thornburg BG, Asrani SK, Fallon MB, Fortune BE, Izzy MJ, Verna EC, Abraldes JG, Allegretti AS, Bajaj JS, Biggins SW, Darcy MD, Farr MA, Farsad K, Garcia-Tsao G, Hall SA, Jadlowiec CC, Krowka MJ, Laberge J, Lee EW, Mulligan DC, Nadim MK, Northup PG, Salem R, Shatzel JJ, Shaw CJ, Simonetto DA, Susman J, Kolli KP, VanWagner LB; Advancing Liver Therapeutic Approaches (ALTA) Consortium. North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension. Clin Gastroenterol Hepatol. 2022 Aug;20(8):1636-1662.e36. doi: 10.1016/j.cgh.2021.07.018. Epub 2021 Jul 15. PMID: 34274511; PMCID: PMC8760361.
  32. Chute DF, Zhao S, Strohbehn IA, Rusibamayila N, Seethapathy H, Lee M, Zubiri L, Gupta S, Leaf DE, Rahma O, Drobni ZD, Neilan TG, Reynolds KL, Sise ME. Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors. Am J Kidney Dis. 2022 Jan;79(1):134-137. doi: 10.1053/j.ajkd.2021.05.012. Epub 2021 Jun 24. PMID: 34174363; PMCID: PMC8855486.
  33. Sise ME, McQuaid T, Martin P. Sofosbuvir-based hepatitis C therapies in patients with chronic and end-stage kidney disease. Nephrol Dial Transplant. 2022 Nov 23;37(12):2327-2334. doi: 10.1093/ndt/gfab072. PMID: 33848334.
  34. Jones BE, Allegretti AS, Pose E, Mara KC, Ufere NN, Avitabile E, Shah VH, Kamath PS, Ginès P, Simonetto DA. Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery. Dig Dis Sci. 2022 Feb;67(2):697-707. doi: 10.1007/s10620-021-06864-z. Epub 2021 Feb 19. PMID: 33604793.
  35. Seethapathy H, Lee MD, Strohbehn IA, Efe O, Rusibamayila N, Chute DF, Colvin RB, Rosales IA, Fadden RM, Reynolds KL, Sullivan RJ, Kaufman HL, Jhaveri KD, Sise ME. Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib. Nephrol Dial Transplant. 2022 Feb 25;37(3):507-514. doi: 10.1093/ndt/gfaa372. PMID: 33355659; PMCID: PMC8875461.

2021

  1. Allegretti AS, Belcher JM. Bile Acids Are Important Contributors to AKI Associated with Liver Disease: CON. Kidney360. 2021 May 4;3(1):21-24. doi: 10.34067/KID.0006512020. PMID: 35378020; PMCID: PMC8967622.
  2. Seethapathy R, Zhao S, Long JD, Strohbehn IA, Sise ME. A Propensity Score- Matched Observational Study of Remdesivir in Patients with COVID-19 and Severe Kidney Disease. Kidney360. 2021 Dec 3;3(2):269-278. doi: 10.34067/KID.0006152021. PMID: 35373125; PMCID: PMC8967642.
  3. Strohbehn IA, Seethapathy R, Lee M, Sise ME. Curative Therapies for Hepatitis C Virus Infection in Patients with Kidney Disease. Kidney360. 2021 May 21;2(8):1316-1325. doi: 10.34067/KID.0001812021. PMID: 35369667; PMCID: PMC8676392.
  4. Shah NB, Nigwekar SU, Kalim S, Lelouvier B, Servant F, Dalal M, Krinsky S, Fasano A, Tolkoff-Rubin N, Allegretti AS. The Gut and Blood Microbiome in IgA Nephropathy and Healthy Controls. Kidney360. 2021 Jun 9;2(8):1261-1274. doi: 10.34067/KID.0000132021. PMID: 35369657; PMCID: PMC8676391.
  5. Lee M, Wang Q, Wanchoo R, Eswarappa M, Deshpande P, Sise ME. Chronic Kidney Disease in Cancer Survivors. Adv Chronic Kidney Dis. 2021 Sep;28(5):469-476.e1. doi: 10.1053/j.ackd.2021.10.007. PMID: 35190113.
  6. Gudsoorkar P, Sise ME, Jhaveri KD. Onconephrology: The Growth of Cancer- Kidney Connection. Adv Chronic Kidney Dis. 2021 Sep;28(5):391-393. doi: 10.1053/j.ackd.2021.12.003. PMID: 35190105.
  7. Sise ME, Goldberg DS, Schaubel DE, Fontana RJ, Kort JJ, Alloway RR, Durand CM, Blumberg EA, Woodle ES, Sherman KE, Brown RS Jr, Friedewald JJ, Desai NM, Sultan ST, Levitsky J, Lee MD, Strohbehn IA, Landis JR, Fernando M, Gustafson JL, Chung RT, Reese PP. One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial. Kidney Int Rep. 2021 Dec 1;7(2):241-250. doi: 10.1016/j.ekir.2021.11.022. PMID: 35155863; PMCID: PMC8820987.
  8. Sinha S, Gould LJ, Nigwekar SU, Serena TE, Brandenburg V, Moe SM, Aronoff G, Chatoth DK, Hymes JL, Miller S, Padgett C, Carroll KJ, Perelló J, Gold A, Chertow GM. The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis. Clin Kidney J. 2021 Jul 6;15(1):136-144. doi: 10.1093/ckj/sfab117. PMID: 35035944; PMCID: PMC8757410.
  9. Bowry SK, Kircelli F, Himmele R, Nigwekar SU. Blood-incompatibility in haemodialysis: alleviating inflammation and effects of coagulation. Clin Kidney J. 2021 Dec 27;14(Suppl 4):i59-i71. doi: 10.1093/ckj/sfab185. PMID: 34987786; PMCID: PMC8711760.
  10. Portales-Castillo IA, Aksu C, Zhao S, Strohbehn I, Sise M, Yu EW, Nigwekar SU. Prescription Patterns of Osteoporosis Medications in Patients With Advanced CKD: A Retrospective Cohort Study. Kidney Med. 2021 Sep 20;3(6):1112-1115. doi: 10.1016/j.xkme.2021.07.005. PMID: 34939026; PMCID: PMC8664743.
  11. Seethapathy H, Herrmann SM, Sise ME. Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management. Kidney Med. 2021 Oct 8;3(6):1074-1081. doi: 10.1016/j.xkme.2021.08.008. PMID: 34939017; PMCID: PMC8664750.
  12. Fishbane SN, Nigwekar S. Phosphate Absorption and Hyperphosphatemia Management in Kidney Disease: A Physiology-Based Review. Kidney Med. 2021 Aug 27;3(6):1057-1064. doi: 10.1016/j.xkme.2021.07.003. PMID: 34939015; PMCID: PMC8664730.
  13. Long JD, Strohbehn I, Sawtell R, Bhattacharyya R, Sise ME. COVID-19 Survival and its impact on chronic kidney disease. Transl Res. 2022 Mar;241:70-82. doi: 10.1016/j.trsl.2021.11.003. Epub 2021 Nov 10. PMID: 34774843; PMCID: PMC8579714.
  14. Yuan Q, Cui H, Leya GA, Hong S, Roth EM, Sise ME, Bethea ED, Yeh H, Williams WW, Elias N. Temporal trends and impact of willingness to accept organs from donors with hepatitis C virus. Transpl Int. 2021 Dec;34(12):2562-2569. doi: 10.1111/tri.14152. Epub 2021 Nov 11. PMID: 34726801.
  15. Gupta S, Short SAP, Sise ME, Prosek JM, Madhavan SM, Soler MJ, Ostermann M, Herrmann SM, Abudayyeh A, Anand S, Glezerman I, Motwani SS, Murakami N, Wanchoo R, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, Seigneux S, Campedel L, Kitchlu A, Shin DS, Rangarajan S, Deshpande P, Coppock G, Eijgelsheim M, Seethapathy H, Lee MD, Strohbehn IA, Owen DH, Husain M, Garcia-Carro C, Bermejo S, Lumlertgul N, Seylanova N, Flanders L, Isik B, Mamlouk O, Lin JS, Garcia P, Kaghazchi A, Khanin Y, Kansal SK, Wauters E, Chandra S, Schmidt-Ott KM, Hsu RK, Tio MC, Sarvode Mothi S, Singh H, Schrag D, Jhaveri KD, Reynolds KL, Cortazar FB, Leaf DE; ICPi-AKI Consortium Investigators. Acute kidney injury in patients treated with immune checkpoint inhibitors. J Immunother Cancer. 2021 Oct;9(10):e003467. doi: 10.1136/jitc-2021-003467. PMID: 34625513; PMCID: PMC8496384.
  16. Molnar MZ, Potluri VS, Schaubel DE, Sise ME, Concepcion BP, Forbes RC, Blumberg E, Bloom RD, Shaffer D, Chung RT, Strohbehn IA, Elias N, Azhar A, Shah M, Sawinski D, Binari LA, Talwar M, Balaraman V, Bhalla A, Eason JD, Besharatian B, Trofe-Clark J, Goldberg DS, Reese PP. Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation. Am J Transplant. 2022 Feb;22(2):599-609. doi: 10.1111/ajt.16834. Epub 2021 Oct 6. PMID: 34613666; PMCID: PMC8968853.
  17. Belcher JM, Parada XV, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Sharma P, Regner KR, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT, Allegretti AS; HRS-HARMONY Study Investigators. Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward. Am J Kidney Dis. 2022 May;79(5):737-745. doi: 10.1053/j.ajkd.2021.08.016. Epub 2021 Oct 2. PMID: 34606933.
  18. Yuan Q, Haque O, Hong S, Ortiz A, Bethea ED, Sise ME, Markmann JF, Elias N. Influence of donor and recipient hepatitis B virus infection on long-term outcomes after kidney transplantation. Clin Transplant. 2021 Dec;35(12):e14466. doi: 10.1111/ctr.14466. Epub 2021 Oct 21. PMID: 34545965.
  19. Zubiri L, Molina GE, Mooradian MJ, Cohen J, Durbin SM, Petrillo L, Boland GM, Juric D, Dougan M, Thomas MF, Faje AT, Rengarajan M, Guidon AC, Chen ST, Okin D, Medoff BD, Nasrallah M, Kohler MJ, Schoenfeld SR, Karp-Leaf RS, Sise ME, Neilan TG, Zlotoff DA, Farmer JR, Bardia A, Sullivan RJ, Blum SM, Semenov YR, Villani AC, Reynolds KL. Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer. J Immunother Cancer. 2021 Sep;9(9):e002886. doi: 10.1136/jitc-2021-002886. Erratum in: J Immunother Cancer. 2021 Oct;9(10): PMID: 34544895; PMCID: PMC8454442.
  20. Drobni ZD, Murphy SP, Alvi RM, Lee C, Gong J, Mosarla RC, Rambarat PK, Hartmann SB, Gilman HK, Zubiri L, Raghu VK, Sullivan RJ, Zafar A, Zlotoff DA, Sise ME, Guidon AC, Reynolds KL, Dougan M, Neilan TG. Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors. Immunother Adv. 2021 Jun 16;1(1):ltab014. doi: 10.1093/immadv/ltab014. PMID: 34541581; PMCID: PMC8444991
  21. Seethapathy H, Street S, Strohbehn I, Lee M, Zhao SH, Rusibamayila N, Chute DF, Gao X, Michaelson MD, Rahma OE, Choueiri TK, McGregor B, Sonpavde G, Salabao C, Kaymakcalan MD, Wei X, Gupta S, Motwani S, Leaf DE, Reynolds KL, Sise ME. Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors. Eur J Cancer. 2021 Nov;157:50-58. doi: 10.1016/j.ejca.2021.07.031. Epub 2021 Sep 2. PMID: 34482189.
  22. Chuang WL, Hu TH, Buggisch P, Moreno C, Su WW, Biancone L, Camargo M, Hyland R, Lu S, Kirby BJ, Dvory-Sobol H, Osinusi A, Gaggar A, Peng CY, Liu CH, Sise ME, Mangia A. Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease. Am J Gastroenterol. 2021 Sep 1;116(9):1924-1928. doi: 10.14309/ajg.0000000000001281. PMID: 34465694.
  23. Strohbehn IA, Street S, Chute D, Seethapathy H, Lee M, Seethapathy R, Drobni ZD, Rahma O, Neilan TG, Zubiri L, Reynolds K, Sise ME. Immune checkpoint inhibitor-induced thyroiditis is a risk factor for acute and chronic kidney dysfunction. Nephrol Dial Transplant. 2021 Dec 31;37(1):187-189. doi: 10.1093/ndt/gfab240. PMID: 34383953; PMCID: PMC8719582.
  24. Strohbehn IA, Zhao S, Seethapathy H, Lee M, Rusibamayila N, Allegretti AS, Parada XV, Sise ME. Acute Kidney Injury Incidence, Recovery, and Long-term Kidney Outcomes Among Hospitalized Patients With COVID-19 and Influenza. Kidney Int Rep. 2021 Oct;6(10):2565-2574. doi: 10.1016/j.ekir.2021.07.008. Epub 2021 Jul 15. PMID: 34307971; PMCID: PMC8280679.
  25. Boike JR, Thornburg BG, Asrani SK, Fallon MB, Fortune BE, Izzy MJ, Verna EC, Abraldes JG, Allegretti AS, Bajaj JS, Biggins SW, Darcy MD, Farr MA, Farsad K, Garcia-Tsao G, Hall SA, Jadlowiec CC, Krowka MJ, Laberge J, Lee EW, Mulligan DC, Nadim MK, Northup PG, Salem R, Shatzel JJ, Shaw CJ, Simonetto DA, Susman J, Kolli KP, VanWagner LB; Advancing Liver Therapeutic Approaches (ALTA) Consortium. North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension. Clin Gastroenterol Hepatol. 2022 Aug;20(8):1636-1662.e36. doi: 10.1016/j.cgh.2021.07.018. Epub 2021 Jul 15. PMID: 34274511; PMCID: PMC8760361.
  26. Ferreira CA, Heidari P, Ataeinia B, Sinevici N, Sise ME, Colvin RB, Wehrenberg-Klee E, Mahmood U. Non-invasive Detection of Immunotherapy-Induced Adverse Events. Clin Cancer Res. 2021 Oct 1;27(19):5353-5364. doi: 10.1158/1078-0432.CCR-20-4641. PMID: 34253581; PMCID: PMC8752648.
  27. Allegretti AS; HRS-HARMONY study investigators. Response to Weng. Clin Transl Gastroenterol. 2021 Jul 12;12(7):e00383. doi: 10.14309/ctg.0000000000000383. PMID: 34251360; PMCID: PMC8443804.
  28. Berg AH, Tavasoli M, Lo AS, Burnett-Bowie SM, Bhan I, Karumanchi SA, Kalim S, Zhang D, Zhao S, Thadhani RI. Development and analytical validation of a novel bioavailable 25-hydroxyvitamin D assay. PLoS One. 2021 Jul 9;16(7):e0254158. doi: 10.1371/journal.pone.0254158. PMID: 34242315; PMCID: PMC8270209.
  29. Allegretti AS, Jamil K, Moore K. Letter: real-world use of terlipressin in patients with the hepatorenal syndrome-authors’ reply. Aliment Pharmacol Ther. 2021 Aug;54(3):350-351. doi: 10.1111/apt.16486. PMID: 34236097.
  30. Reynolds KL, Arora S, Elayavilli RK, Louv WC, Schaller TH, Khandelwal A, Rothenberg M, Khozin S, Guidon AC, Dougan M, Zubiri L, Petrillo L, Sise ME, Villani AC, Johnson DB, Rahma O, Sharon E. Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data. J Immunother Cancer. 2021 Jul;9(7):e002896. doi: 10.1136/jitc-2021-002896. PMID: 34215691; PMCID: PMC8256840.
  31. Chute DF, Zhao S, Strohbehn IA, Rusibamayila N, Seethapathy H, Lee M, Zubiri L, Gupta S, Leaf DE, Rahma O, Drobni ZD, Neilan TG, Reynolds KL, Sise ME. Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors. Am J Kidney Dis. 2022 Jan;79(1):134-137. doi: 10.1053/j.ajkd.2021.05.012. Epub 2021 Jun 24. PMID: 34174363; PMCID: PMC8855486.
  32. Gabel CK, Chakrala T, Dobry AS, Garza-Mayers AC, Ko LN, Nguyen ED, Shah R, St John J, Nigwekar SU, Kroshinsky D. The Koebner phenomenon may contribute to the development of calciphylaxis: A case series. JAAD Case Rep. 2021 Apr 28;13:57-61. doi: 10.1016/j.jdcr.2021.04.016. PMID: 34159240; PMCID: PMC8193369.
  33. Gong J, Drobni ZD, Zafar A, Quinaglia T, Hartmann S, Gilman HK, Raghu VK, Gongora C, Sise ME, Alvi RM, Zubiri L, Nohria A, Sullivan R, Reynolds KL, Zlotoff D, Neilan TG. Pericardial disease in patients treated with immune checkpoint inhibitors. J Immunother Cancer. 2021 Jun;9(6):e002771. doi: 10.1136/jitc-2021-002771. PMID: 34145031; PMCID: PMC8215235.
  34. Street S, Chute D, Strohbehn I, Zhao S, Rengarajan M, Faje A, Seethapathy H, Lee M, Seethapathy R, Drobni Z, Rahma O, Neilan TG, Sullivan RJ, Villani AC, Zubiri L, Mooradian MJ, Reynolds KL, Sise ME. The positive effect of immune checkpoint inhibitor-induced thyroiditis on overall survival accounting for immortal time bias: a retrospective cohort study of 6596 patients. Ann Oncol. 2021 Aug;32(8):1050-1051. doi: 10.1016/j.annonc.2021.05.357. Epub 2021 May 19. PMID: 34020034; PMCID: PMC8814352.
  35. Allegretti AS, Parada XV, Endres P, Zhao S, Krinsky S, St Hillien SA, Kalim S, Nigwekar SU, Flood JG, Nixon A, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Regner KR, Belcher JM, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT; HRS-HARMONY study investigators. Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study. Clin Transl Gastroenterol. 2021 May 11;12(5):e00359. doi: 10.14309/ctg.0000000000000359. PMID: 33979307; PMCID: PMC8116001.
  36. Kalim S, Lyons KS, Nigwekar SU. Opioids in Hemodialysis Patients. Semin Nephrol. 2021 Jan;41(1):24-32. doi: 10.1016/j.semnephrol.2021.02.003. PMID: 33896471; PMCID: PMC8083988.
  37. Lee MD, Seethapathy H, Strohbehn IA, Zhao SH, Boland GM, Fadden R, Sullivan R, Reynolds KL, Sise ME. Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study. J Immunother Cancer. 2021 Apr;9(4):e002292. doi: 10.1136/jitc-2020-002292. PMID: 33849926; PMCID: PMC8051410.
  38. Gabel CK, Blum AE, François J, Chakrala T, Dobry AS, Garza-Mayers AC, Ko LN, Nguyen ED, Shah R, John JS, Nigwekar SU, Kroshinsky D. Clinical mimickers of calciphylaxis: A retrospective study. J Am Acad Dermatol. 2021 Dec;85(6):1520-1527. doi: 10.1016/j.jaad.2021.03.035. Epub 2021 Mar 17. PMID: 33744358.
  39. Timms L, Zhou T, Lyu Y, Qiao J, Mishra V, Lahoud RM, Jayaraman GV, Allegretti AS, Drew D, Seethamraju RT, Harisinghani M, Sridhar S. Ferumoxytol- enhanced ultrashort TE MRA and quantitative morphometry of the human kidney vasculature. Abdom Radiol (NY). 2021 Jul;46(7):3288-3300. doi: 10.1007/s00261-021-02984-2. Epub 2021 Mar 5. PMID: 33666735; PMCID: PMC8217117.
  40. Kalim S, Berg AH, Karumanchi SA, Thadhani R, Allegretti AS, Nigwekar S, Zhao S, Srivastava A, Raj D, Deo R, Frydrych A, Chen J, Sondheimer J, Shafi T, Weir M, Lash JP; CRIC Study Investigators. Protein carbamylation and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study. Nephrol Dial Transplant. 2021 Dec 31;37(1):139-147. doi: 10.1093/ndt/gfaa347. PMID: 33661286; PMCID: PMC8719615.
  41. Molina GE, Zubiri L, Cohen JV, Durbin SM, Petrillo L, Allen IM, Murciano- Goroff YR, Dougan M, Thomas MF, Faje AT, Rengarajan M, Guidon AC, Chen ST, Okin D, Medoff BD, Nasrallah M, Kohler MJ, Schoenfeld SR, Karp Leaf RS, Sise ME, Neilan TG, Zlotoff DA, Farmer JR, Mooradian MJ, Bardia A, Mai M, Sullivan RJ, Semenov YR, Villani AC, Reynolds KL. Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018. Oncologist. 2021 Jun;26(6):514-522. doi: 10.1002/onco.13740. Epub 2021 Mar 31. PMID: 33655682; PMCID: PMC8176966.
  42. Olaniran KO, Allegretti AS, Zhao SH, Nigwekar SU, Kalim S. Acute Kidney Injury among Black Patients with Sickle Cell Trait and Sickle Cell Disease. Clin J Am Soc Nephrol. 2021 Mar 8;16(3):348-355. doi: 10.2215/CJN.06960520. PMID: 33648973; PMCID: PMC8011026.
  43. Jones BE, Allegretti AS, Pose E, Mara KC, Ufere NN, Avitabile E, Shah VH, Kamath PS, Ginès P, Simonetto DA. Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery. Dig Dis Sci. 2022 Feb;67(2):697-707. doi: 10.1007/s10620-021-06864-z. Epub 2021 Feb 19. PMID: 33604793.
  44. Ayus JC, Nigwekar SU, Negri AL. Risks of Hip and Nonvertebral Fractures in Patients With CKD. Am J Kidney Dis. 2021 Apr;77(4):546. doi: 10.1053/j.ajkd.2020.10.018. Epub 2021 Feb 12. PMID: 33589288.
  45. Seethapathy H, Rusibamayila N, Chute DF, Lee M, Strohbehn I, Zubiri L, Faje AT, Reynolds KL, Jhaveri KD, Sise ME. Hyponatremia and other electrolyte abnormalities in patients receiving immune checkpoint inhibitors. Nephrol Dial Transplant. 2021 Dec 2;36(12):2241-2247. doi: 10.1093/ndt/gfaa272. PMID: 33374011; PMCID: PMC8643613.
  46. Murakami N, Mulvaney P, Danesh M, Abudayyeh A, Diab A, Abdel-Wahab N, Abdelrahim M, Khairallah P, Shirazian S, Kukla A, Owoyemi IO, Alhamad T, Husami S, Menon M, Santeusanio A, Blosser CD, Zuniga SC, Soler MJ, Moreso F, Mithani Z, Ortiz-Melo D, Jaimes EA, Gutgarts V, Lum E, Danovitch GM, Cardarelli F, Drews RE, Bassil C, Swank JL, Westphal S, Mannon RB, Shirai K, Kitchlu A, Ong S, Machado SM, Mothi SS, Ott PA, Rahma O, Hodi FS, Sise ME, Gupta S, Leaf DE, Devoe CE, Wanchoo R, Nair VV, Schmults CD, Hanna GJ, Sprangers B, Riella LV, Jhaveri KD; Immune Checkpoint Inhibitors in Solid Organ Transplant Consortium. A multi- center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant. Kidney Int. 2021 Jul;100(1):196-205. doi: 10.1016/j.kint.2020.12.015. Epub 2020 Dec 24. PMID: 33359528; PMCID: PMC8222056.
  47. Estiverne C, Strohbehn IA, Mithani Z, Hirsch JS, Wanchoo R, Goyal PG, Lee Dryden-Peterson S, Pearson JC, Kubiak DW, Letourneau AR, Bhattacharyya R, Jhaveri KD, Sise ME. Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m<sup>2</sup> or on Renal Replacement Therapy. Kidney Int Rep. 2021 Mar;6(3):835-838. doi: 10.1016/j.ekir.2020.11.025. Epub 2020 Nov 27. PMID: 33263094; PMCID: PMC7694470.
  48. Nguyen T, Sise ME, Delgado C, Williams W, Reese P, Goldberg D. Race, Education, and Gender Disparities in Transplantation of Kidneys From Hepatitis C Viremic Donors. Transplantation. 2021 Aug 1;105(8):1850-1857. doi: 10.1097/TP.0000000000003511. PMID: 33141804; PMCID: PMC8842824.
  49. Gabel CK, Nguyen ED, Chakrala T, Blum AE, François J, Chand S, Rrapi R, Baker O, Dobry AS, Garza-Mayers AC, Ko LN, Shah R, St John J, Nigwekar SU, Kroshinsky D. Assessment of outcomes of calciphylaxis. J Am Acad Dermatol. 2021 Oct;85(4):1057-1064. doi: 10.1016/j.jaad.2020.10.067. Epub 2020 Oct 29. PMID: 33130181.
  50. Chewcharat A, Chang YT, Sise ME, Bhattacharyya RP, Murray MB, Nigwekar SU. Phase-3 Randomized Controlled Trials on Exclusion of Participants With Kidney Disease in COVID-19. Kidney Int Rep. 2021 Jan;6(1):196-199. doi: 10.1016/j.ekir.2020.10.010. Epub 2020 Oct 21. PMID: 33106779; PMCID: PMC7577277.
  51. Lee MD, Strohbehn IA, Seethapathy HS, Rusibamayila N, Casey KS, Gupta S, Leaf DE, Frigault MJ, Sise ME. Acute Kidney Injury After the CAR-T Therapy Tisagenlecleucel. Am J Kidney Dis. 2021 Jun;77(6):990-992. doi: 10.1053/j.ajkd.2020.08.017. Epub 2020 Oct 22. PMID: 33098925; PMCID: PMC8060348.
  52. Gupta S, Coca SG, Chan L, Melamed ML, Brenner SK, Hayek SS, Sutherland A, Puri S, Srivastava A, Leonberg-Yoo A, Shehata AM, Flythe JE, Rashidi A, Schenck EJ, Goyal N, Hedayati SS, Dy R, Bansal A, Athavale A, Nguyen HB, Vijayan A, Charytan DM, Schulze CE, Joo MJ, Friedman AN, Zhang J, Sosa MA, Judd E, Velez JCQ, Mallappallil M, Redfern RE, Bansal AD, Neyra JA, Liu KD, Renaghan AD, Christov M, Molnar MZ, Sharma S, Kamal O, Boateng JO, Short SAP, Admon AJ, Sise ME, Wang W, Parikh CR, Leaf DE; STOP-COVID Investigators. AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19. J Am Soc Nephrol. 2021 Jan;32(1):161-176. doi: 10.1681/ASN.2020060897. Epub 2020 Oct 16. PMID: 33067383; PMCID: PMC7894677.
  53. Gabel CK, Nguyen ED, Dobry AS, Baker O, Garza-Mayers AC, Ko LN, Shah R, St John J, Strazzula L, Nigwekar SU, Kroshinsky D. Assessment of outcomes of calciphylaxis lesions treated with intralesional sodium thiosulfate. J Am Acad Dermatol. 2021 Sep;85(3):770-773. doi: 10.1016/j.jaad.2020.07.090. Epub 2020 Jul 28. PMID: 32735974.
  54. Gabel C, Chakrala T, Shah R, Danesh MJ, Dobry AS, Garza-Mayers AC, Ko LN, Nguyen E, St John J, Walls AC, Nigwekar SU, Song PI, Kroshinsky D. Penile calciphylaxis: A retrospective case-control study. J Am Acad Dermatol. 2021 Nov;85(5):1209-1217. doi: 10.1016/j.jaad.2020.05.042. Epub 2020 May 15. PMID: 32422224.

2020

  1. Allegretti AS. Acute Kidney Injury Treatment in Decompensated Cirrhosis: A Focus on Kidney Replacement Therapy. Kidney Med. 2020 Dec 5;3(1):12-14. doi: 10.1016/j.xkme.2020.09.015. PMID: 33604536; PMCID: PMC7873819.
  2. Estiverne C, Strohbehn IA, Mithani Z, Hirsch JS, Wanchoo R, Goyal PG, Lee Dryden-Peterson S, Pearson JC, Kubiak DW, Letourneau AR, Bhattacharyya R, Jhaveri KD, Sise ME. Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m2or on Renal Replacement Therapy. Kidney Int Rep. 2021 Mar;6(3):835-838. doi: 10.1016/j.ekir.2020.11.025. Epub 2020 Nov 27. PMID: 33263094; PMCID: PMC7694470.
  3. Makhmudi A, Wirohadidjojo YW, Gahara E, Noor HZ, Sunardi M, Mahmudah NA, Kalim AS, Gunadi. A novel wound healing accelerator: Effect of vitreous gel of cow eyeball on a chronic wound model. Med J Malaysia. 2020 Nov;75(6):698-704. PMID: 33219180.
  4. Lee MD, Strohbehn IA, Seethapathy HS, Rusibamayila N, Casey KS, Gupta S, Leaf DE, Frigault MJ, Sise ME. Acute Kidney Injury After the CAR-T Therapy Tisagenlecleucel. Am J Kidney Dis. 2021 Jun;77(6):990-992. doi: 10.1053/j.ajkd.2020.08.017. Epub 2020 Oct 22. PMID: 33098925; PMCID: PMC8060348.
  5. Chewcharat A, Chang YT, Sise ME, Bhattacharyya RP, Murray MB, Nigwekar SU. Phase-3 Randomized Controlled Trials on Exclusion of Participants With Kidney Disease in COVID-19. Kidney Int Rep. 2021 Jan;6(1):196-199. doi: 10.1016/j.ekir.2020.10.010. Epub 2020 Oct 21. PMID: 33106779; PMCID: PMC7577277.
  6. Endres P, Rosovsky R, Zhao S, Krinsky S, Percy S, Kamal O, Roberts RJ, Lopez N, Sise ME, Steele DJR, Lundquist AL, Rhee EP, Hibbert KA, Hardin CC, Mc Causland FR, Czarnecki PG, Mutter W, Tolkoff-Rubin N, Allegretti AS. Filter clotting with continuous renal replacement therapy in COVID-19. J Thromb Thrombolysis. 2021 May;51(4):966-970. doi: 10.1007/s11239-020-02301-6. Epub 2020 Oct 7. PMID: 33026569; PMCID: PMC7539277.
  7. Moore K, Jamil K, Allegretti AS. Letter: HRS-AKI-a frequent misdiagnosis in the real world setting? Authors’ reply. Aliment Pharmacol Ther. 2020 Sep;52(6):1092. doi: 10.1111/apt.16001. PMID: 33119161.
  8. Allegretti AS, Jamil K, Moore K. Editorial: treating hepatorenal syndrome-a window and the views. Authors’ reply. Aliment Pharmacol Ther. 2020 Sep;52(5):897. doi: 10.1111/apt.15981. PubMed PMID: 32852830.
  9. Seethapathy H, Zhao S, Strohbehn IA, Lee M, Chute DF, Bates H, Molina GE, Zubiri L, Gupta S, Motwani S, Leaf DE, Sullivan RJ, Rahma O, Blumenthal KG, Villani AC, Reynolds KL, Sise ME. Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors. Kidney Int Rep. 2020 Jul 21;5(10):1700-1705. doi: 10.1016/j.ekir.2020.07.011. PMID: 33102962; PMCID: PMC7569697.
  10. Allegretti AS, Solà E, Ginès P. Clinical Application of Kidney Biomarkers in Cirrhosis. Am J Kidney Dis. 2020 Nov;76(5):710-719. doi: 10.1053/j.ajkd.2020.03.016. Epub 2020 Jul 1. Review. PubMed PMID: 32622560.
  11. Battistone MA, Mendelsohn AC, Spallanzani RG, Allegretti AS, Liberman RN, Sesma J, Kalim S, Wall SM, Bonventre JV, Lazarowski ER, Brown D, Breton S. Proinflammatory P2Y14 receptor inhibition protects against ischemic acute kidney injury in mice. J Clin Invest. 2020 Jul 1;130(7):3734-3749. doi: 10.1172/JCI134791. PubMed PMID: 32287042; PubMed Central PMCID: PMC7324186.
  12. Johnson DB, Jakubovic BD, Sibaud V, Sise ME. Balancing Cancer Immunotherapy Efficacy and Toxicity. J Allergy Clin Immunol Pract. 2020 Oct;8(9):2898-2906. doi: 10.1016/j.jaip.2020.06.028. Epub 2020 Jun 26. PMID: 32599218; PMCID: PMC7318967.
  13. Adamsick ML, Gandhi RG, Bidell MR, Elshaboury RH, Bhattacharyya RP, Kim AY, Nigwekar S, Rhee EP, Sise ME. Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19. J Am Soc Nephrol. 2020 Jul;31(7):1384-1386. doi: 10.1681/ASN.2020050589. Epub 2020 Jun 8. PMID: 32513665; PMCID: PMC7351006.
  14. Moore K, Jamil K, Verleger K, Luo L, Kebede N, Heisen M, Corman S, Leonardi R, Bakker R, Maï C, Shamseddine N, Huang X, Allegretti AS. Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome. Aliment Pharmacol Ther. 2020 Jul;52(2):351-358. doi: 10.1111/apt.15836. Epub 2020 Jun 4. PMID: 32495956; PMCID: PMC7383732.
  15. Seethapathy H, Sharma S, Zhao S, Chung RT, Connor MJ Jr, Leaf DE, Allegretti AS. Acute Kidney Injury Following Paracentesis Among Inpatients With Cirrhosis. Kidney Int Rep. 2020 May 20;5(8):1305-1308. doi: 10.1016/j.ekir.2020.05.014. PMID: 32775831; PMCID: PMC7403547.
  16. Strohbehn IA, Lee M, Seethapathy H, Chute D, Rahma O, Guidon A, Neilan TG, Zlotoff DA, Okin D, Rengarajan M, Reynolds K, Sise ME. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients on Dialysis: A Retrospective Case Series. Am J Kidney Dis. 2020 Aug;76(2):299-302. doi: 10.1053/j.ajkd.2020.02.451. Epub 2020 May 15. PMID: 32417401; PMCID: PMC7997681.
  17. Seethapathy H, Bates H, Chute DF, Strohbehn I, Strohbehn S, Fadden RM, Reynolds KL, Cohen JV, Sullivan RJ, Sise ME. Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma. Kidney Med. 2020 Apr 18;2(3):373-375. doi: 10.1016/j.xkme.2020.01.012. PMID: 32734258; PMCID: PMC7380350.
  18. Reddy YNV, Reddy KP, Sise ME. HCV-Infected Deceased Donor Kidney Transplantation-Time to Take Up the Offer. Am J Kidney Dis. 2020 Jun;75(6):827-829. doi: 10.1053/j.ajkd.2020.01.010. Epub 2020 Apr 18. PMID: 32317120; PMCID: PMC7247921.
  19. Allegretti AS, Endres P, Parris T, Zhao S, May M, Sylvia-Reardon M, Bezreh N, Culbert-Costley R, Ananian L, Roberts RJ, Lopez N, Charytan DM, Tolkoff-Rubin N. Accelerated Venovenous Hemofiltration as a Transitional Renal Replacement Therapy in the Intensive Care Unit. Am J Nephrol. 2020;51(4):318-326. doi: 10.1159/000506412. Epub 2020 Feb 25. PubMed PMID: 32097936.
  20. Gupta S, Seethapathy H, Strohbehn IA, Frigault MJ, O’Donnell EK, Jacobson CA, Motwani SS, Parikh SM, Curhan GC, Reynolds KL, Leaf DE, Sise ME. Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma. Am J Kidney Dis. 2020 Jul;76(1):63-71. doi: 10.1053/j.ajkd.2019.10.011. Epub 2020 Jan 20. PMID: 31973908; PMCID: PMC7311244.
  21. Olaniran KO, Eneanya ND, Zhao SH, Ofsthun NJ, Maddux FW, Thadhani RI, Dalrymple LS, Nigwekar SU. Mortality and Hospitalizations among Sickle Cell Disease Patients with End-Stage Kidney Disease Initiating Dialysis. Am J Nephrol. 2020;51(12):995-1003. doi: 10.1159/000513012. Epub 2021 Jan 22. PMID: 33486484.

2019

  1. Olaniran KO, Allegretti AS, Zhao SH, Achebe MM, Eneanya ND, Thadhani RI, Nigwekar SU, Kalim S. Kidney Function Decline among Black Patients with Sickle Cell Trait and Sickle Cell Disease: An Observational Cohort Study. J Am Soc Nephrol. 2019 Dec 06. PMID: 31810990.
  2. Seethapathy H, Zhao S, Chute DF, Zubiri L, Oppong Y, Strohbehn I, Cortazar FB, Leaf DE, Mooradian MJ, Villani AC, Sullivan RJ, Reynolds K, Sise ME. The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors. Clin J Am Soc Nephrol. 2019 Dec 06; 14(12):1692-1700. PMID: 31672794.
  3. Olaniran KO, Seethapathy H, Zhao SH, Allegretti AS, Kalim S, Nigwekar SU. Validity of International Classification of Diseases Codes for Sickle Cell Trait and Sickle Cell Disease. J Gen Intern Med. 2019 Nov 19. PMID: 31745854.
  4. Larsen DM, Tangren JS. Trends in Chronic Hypertension in Pregnancy Highlight Racial Disparities in Maternal Health. Hypertension. 2019 11; 74(5):1087-1088. PMID: 31495280.
  5. Lim K, Kalim S. The Role of Nonenzymatic Post-translational Protein Modifications in Uremic Vascular Calcification. Adv Chronic Kidney Dis. 2019 Nov; 26(6):427-436. PMID: 31831121.
  6. Lim, K., and Kalim, S. “Role of post translational protein modifications in uremic vascular calcification”. Advances in Chronic Kidney Disease (ACKD). 2019 Nov;26(6):427-436.
  7. Nigwekar SU, Negri AL, Bajpai D, Allegretti A, Kalim S, Seethapathy H, Bhan I, Murthy K, Ayus JC. Chronic prolonged hyponatremia and risk of hip fracture in elderly patients with chronic kidney disease. Bone. 2019 Oct; 127:556-562. PMID: 31362067.
  8. Tangren JS, Thadhani R. Novel Preeclampsia Diagnostics and Real-World Applications. Hypertension. 2019 10; 74(4):740-742. PMID: 31401879.
  9. Lim, K., Halim, A., Lu.T.S., Ashworth, A., Chong, I. “Klotho: A major shareholder in vascular aging enterprises”. International Journal of Molecular Sciences (IJMS). 2019, Sep 19;20(18).
  10. Seethapathy H, Fenves AZ. Pathophysiology and Management of Hyperammonemia in Organ Transplant Patients. Am J Kidney Dis. 2019 Sep; 74(3):390-398. PMID: 31040091.
  11. Seethapathy H, Nigwekar SU. Revisiting therapeutic options for calciphylaxis. Curr Opin Nephrol Hypertens. 2019 Sep; 28(5):448-454. PMID: 31169527.
  12. Colucci LA, Corapi KM, Li M, Parada XV, Allegretti AS, Lin HY, Ausiello DA, Rosen MS, Cima MJ. Fluid assessment in dialysis patients by point-of-care magnetic relaxometry. Sci Transl Med. 2019 Jul 24;11(502). doi: 10.1126/scitranslmed.aau1749. PubMed PMID: 31341060.
  13. Sise ME, Seethapathy H, Reynolds KL. Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review. Oncologist. 2019 Jun; 24(6):735-742. PMID: 30902916.
  14. Allegretti AS, Frenk NE, Li DK, Seethapathy H, Vela Parada XF, Long J, Endres P, Pratt DS, Chung RT, Ganguli S, Irani Z, Yamada K. Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement. PLoS One. 2019;14(5):e0217442. doi: 10.1371/journal.pone.0217442. eCollection 2019. PubMed PMID: 31120995; PubMed Central PMCID: PMC6533008.
  15. Shah NB, Allegretti AS, Nigwekar SU, Kalim S, Zhao S, Lelouvier B, Servant F, Serena G, Thadhani RI, Raj DS, Fasano A. Blood Microbiome Profile in CKD : A Pilot Study. Clin J Am Soc Nephrol. 2019 May 07; 14(5):692-701. PMID: 30962186.
  16. Sise, M. E., D. F. Chute, Y. Oppong, M. I. Davis, J. D. Long, S. T. Silva, N. Rusibamayila, D. Jean-Francois, S. Raji, S. Zhao, R. Thadhani and R. T. Chung “Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease.” Kidney International. 2019 May.
  17. Hiemstra, T., Lim, K., Thadhani, R. and Manson, J. “Vitamin D and Cardiovascular Disease”. Journal of Clinical Endocrinology & Metabolism (JCEM). 2019, Apr 4. pii: jc.2019-00194.
  18. Allegretti AS, Zhang W, Zhou W, Thurber T, Rigby SP, Bowman-Stroud C, Trescoli C, Serusclat P, Freeman MW, Halvorsen Y. Safety and Effectiveness of Bexagliflozin in Patients with Type 2 Diabetes Mellitus and Stage 3a/3b Chronic Kidney Disease. Am J Kid Dis. Accepted for publication. 2019 March 17.
  19. Allegretti AS, Vela Parada X, Ortiz GA, Long J, Krinsky S, Zhao S, Fuchs BC, Sojoodi M, Zhang D, Karumanchi SA, Kalim S, Nigwekar SU, Thadhani RI, Parikh SM, Chung RT. Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis. Hepatology. 2019 Feb;69(2):729-741. doi: 10.1002/hep.30230. Epub 2019 Jan 4. PubMed PMID: 30141205; PubMed Central PMCID: PMC6351209.
  20. Olaniran KO, Percy SG, Zhao S, Blais C, Jackson V, Kamdar MM, Goverman J, Kroshinsky D, Temel JS, Nigwekar SU, Eneanya ND. Palliative Care Use and Patterns of End-of-Life Care in Hospitalized Patients with Calciphylaxis. J Pain Symptom Manage. 2019 Feb;57(2):e1-e3.
  21. Lyu H, Yoshida K, Tedeschi SK, Zhao S, Xu C, Nigwekar SU, Leder BZ, Solomon DH. Intervals between bone mineral density testing with dual-energy X-ray absorptiometry scans in clinical practice. Osteoporos Int. 2019 Jan 24.
  22. Cozzolino M, Mangano M, Galassi A, Ciceri P, Messa P, Nigwekar S. Vitamin K in Chronic Kidney Disease. Nutrients. 2019 Jan 14;11(1). pii: E168.
  23. Olaniran KO, Eneanya ND, Allegretti AS, Zhao SH, Achebe MM, Thadhani RI. Cardiovascular Outcomes in African Americans with Sickle Cell Trait and Chronic Kidney Disease. Am J Nephrol. 2019;49(2):93-102. doi: 10.1159/000496058. Epub 2019 Jan 9. PubMed PMID: 30625463.
  24. Garlo KG, Steele DJR, Nigwekar SU, Chan KE. Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in Chronic Kidney Disease. Clin J Am Soc Nephrol. Clin J Am Soc Nephrol. 2019 Jan 7;14(1):125-136
  25. Portales-Castillo I, Kroshinksy D, Malhotra CK, Culbert-Costley R, Cozzolino MG, Karparis S, Halasz CL, Goverman J, Manley HJ, Malhotra R, Nigwekar SU. Calciphylaxis-as a drug induced adverse event. Expert Opin Drug Saf. 2019 Jan;18(1):29-35.
  26. Seethapathy H, Brandenburg VM, Sinha S, El-Azhary RA, Nigwekar SU. Update on the Management of Calciphylaxis. QJM. 2019 Jan 1;112(1):29-34.
  27. Lim, K., Ting, S., Hamborg, T., McGregor, G, Oxborough, D., Tomkins, C., Xu, D., Bland, R., Banerjee, P., Fletcher, S., Nithya, K., Higgins, R., Hiemstra, T. and Zehnder, D. “Improved cardiovascular functional reserve following kidney transplantation: The CAPER prospective concurrent control study”. JAMA Cardiology.
  28. Lim, K., and Thadhani, R. “Vitamin D intoxication”. Brazilian Journal of Nephrology (BJN).
2018
  1. Verberne WR, Das-Gupta Z, Allegretti AS, Bart JAJ, van Biesen W, Garcia-Garcia G, Gibbons E, Parra Moncasi E, Hemmelder MH, Jager KJ, Ketteler M, Konowitz L, Al Rohani M, Stopper A, Terkivatan T, Tuttle KR, Yang CW, Wheeler DC, Roberts C, Bos WJW. Development of an International Standard Set of Value-Based Outcome Measures for Patients With Chronic Kidney Disease. Am J Kidney Dis. 2018 Dec 19. doi: 10.1053/j.ajkd.2018.10.007. [Epub ahead of print]
  2. Lyu H, Jundi B, Xu C, Tedeschi SK, Yoshida K, Zhao S, Nigwekar SU, Leder BZ, Solomon DH. Comparison of denosumab vs. bisphosphonates in osteoporosis patients: A meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2018 Dec 10. doi: 10.1210/jc.2018-02236. [Epub ahead of print]
  3. Blaha T, Nigwekar S, Combs S, Kaw U, Krishnappa V, Raina R. Dermatologic manifestations in end stage renal disease. Hemodial Int. 2018 Dec 6. doi: 10.1111/hdi.12689. [Epub ahead of print]
  4. Olaniran KO, Eneanya ND, Nigwekar SU, Vela-Parada XF, Achebe MM, Sharma A, Thadhani RI. Sickle Cell Nephropathy in the Pediatric Population. Blood Purif. 2018 Dec 5:1-9. doi: 10.1159/000494581. [Epub ahead of print]
  5. Henson JB, Sise ME. The association of hepatitis C infection with the onset of CKD and progression into ESRD. Semin Dial. 2018 Nov 29. doi: 10.1111/sdi.12759. [Epub ahead of print]
  6. Kalim S. Protein carbamylation in end stage renal disease: is there a mortality effect? Curr Opin Nephrol Hypertens. 2018 Nov;27(6):454-462.
  7. Long JD, Rutledge SM, Sise ME. Autoimmune Kidney Diseases Associated with Chronic Viral Infections. Rheum Dis Clin North Am. 2018 Nov;44(4):675-698.
  8. Bomback AS, Sise ME. A Three-Headed Approach to Kidney Involvement in Rheumatic Diseases. Rheum Dis Clin North Am. 2018 Nov; 44(4):xiii-xiv.
  9. Liu H, Zhao S. Savings Opportunity from Improved CKD Care Management. JASN November 2018, 29 (11) 2612-2615.
  10. Nigwekar SU, Thadhani R. Long-Term Anticoagulation for Patients Receiving Dialysis. Circulation. 2018 Oct 9;138(15):1530-1533.
  11. Williams EA, Moy AP, Cipriani NA, Nigwekar SU, Nazarian RM. Factors associated with false-negative pathologic diagnosis of calciphylaxis. J Cutan Pathol. 2018 Oct 2.
  12. Liu H, Zhao, S. Savings Opportunity from Improved CKD Care Management. J Am Soc Nephrol 29 October 2018.
  13. Powe CE, Nodzenski M, Talbot O, Allard C, Briggs C, Leya MV, Perron P, Bouchard L, Florez JC, Scholtens DM, Lowe WL Jr, Hivert MF. Genetic Determinants of Glycemic Traits and the Risk of Gestational Diabetes Mellitus. Diabetes. 2018 Sep 26.
  14. Garza-Mayers AC, Shah R, Sykes DB, Nigwekar SU, Kroshinsky D. The Successful Use of Apixaban in Dialysis Patients with Calciphylaxis Who Require Anticoagulation: A Retrospective Analysis. Am J Nephrol. 2018 Sep 3;48(3):168-171.
  15. Bajaj R, Courbebaisse M, Kroshinsky D, Thadhani RI, Nigwekar SU. Calciphylaxis in Patients With Normal Renal Function: A Case Series and Systematic Review. Mayo Clin Proc. 2018 Sep;93(9):1202-1212.
  16. Long J, Vela Parada X, Kalim S. Protein Carbamylation in Chronic Kidney Disease and Dialysis. Adv Clin Chem. 2018;87:37-67. Epub 2018 Aug 23.
  17. Eneanya ND, Olaniran K, Xu D, Waite K, Crittenden S, Hazar DB, Volandes AE, Temel JS, Thadhani R, Paasche-Orlow MK. Health Literacy Mediates Racial Disparities in Cardiopulmonary Resuscitation Knowledge among Chronic Kidney Disease Patients. J Health Care Poor Underserved. 2018;29(3):1069-1082.
  18. Nigwekar SU, Nazarian RM. Cutaneous calcification in patients with kidney disease is not always calciphylaxis. Kidney Int. 2018 Aug;94(2):244-246.
  19. Wexler DJ, Powe CE, Barbour LA, Buchanan T, Coustan DR, Corcoy R, Damm P, Dunne F, Feig DS, Ferrara A, Harper LM, Landon MB, Meltzer SJ, Metzger BE, Roeder H, Rowan JA, Sacks DA, Simmons D, Umans JG, Catalano PM. Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. Obstet Gynecol. 2018 Aug;132(2):496-505.
  20. Tangren JS, Wan Md Adnan WAH, Powe CE, Ecker J, Bramham K, Hladunewich MA, Ankers E, Karumanchi SA, Thadhani R. Risk of Preeclampsia and Pregnancy Complications in Women With a History of Acute Kidney Injury. Hypertension. 2018 Aug;72(2):451-459.
  21. Tangren JS. Can Blood Pressure Self-Monitoring Improve Postpartum Management of Pregnancy-Associated Hypertension? Hypertension. 2018 Aug;72(2):296-297.
  22. Sise ME. Hepatitis C virus infection and the kidney. Nephrol Dial Transplant. 2018 Jul 27.
  23. Allegretti JR, Allegretti AS, Phelps E, Xu H, Kassam Z, Fischer M. Asymptomatic Clostridium difficile carriage rate post-fecal microbiota transplant is low: a prospective clinical and stool assessment. Clin Microbiol Infect. 2018 Jul;24(7):780.e1-780.e3.
  24. Tang M, Batty JA, Lin C, Fan X, Chan KE, Kalim S. Pulmonary Hypertension, Mortality, and Cardiovascular Disease in CKD and ESRD Patients: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2018 Jul;72(1):75-83.
  25. Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med. 2018 Jul 26;379(4):399-400.
  26. Allegretti AS, Israelsen M, Krag A, Jovani M, Goldin AH, Schulman AR, Winter RW, Gluud LL. Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome. Cochrane Database Syst Rev. 2017 Jun 14;6:CD005162.
  27. Lin B, Srikanth P, Castle AC, Nigwekar S, Malhotra R, Galloway JL, Sykes DB, Rajagopal J. Modulating Cell Fate as a Therapeutic Strategy. Cell Stem Cell. 2018 May 23.
  28. Allegretti AS, Thadhani RI. Epidemiology: Chronic disease, cancer, and exercise – a common link. Nat Rev Nephrol. 2018 May; 14(5):288-290
  29. Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med. 2018 May 3;378(18):1704-1714.
  30. Tangren JS, Powe CE, Ecker J, Bramham K, Ankers E, Karumanchi SA, Thadhani R. Metabolic and Hypertensive Complications of Pregnancy in Women with Nephrolithiasis. Clin J Am Soc Nephrol. 2018 Apr 6;13(4):612-619. PMCID: PMC5969466.
  31. Rutledge SM, Chung RT, Sise ME. Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis. Hemodial Int. 2018 Apr;22 Suppl 1:S81-S96.
  32. Sise ME, Chute DF, Gustafson JL, Wojciechowski D, Elias N, Chung RT, Williams WW. Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients. Hemodial Int. 2018 Apr;22 Suppl 1:S71-S80.
  33. Chute DF, Sise ME. Effect of the Opioid Crisis on the Donor Pool for Kidney Transplantation: An Analysis of National Kidney Deceased Donor Trends from 2010-2016. Am J Nephrol. 2018;47(2):84-93.
  34. Chute DF, Chung RT, Sise ME. Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient. Kidney Int. 2018 Mar;93(3):560-567.
  35. Tangren J, Nadel M, Hladunewich MA. Pregnancy and End-Stage Renal Disease. Blood Purif. 2018;45(1-3):194-200.
  36. Trottier C, Perl J, Freeman M, Thadhani R, Berg A, Kalim S. Protein Carbamylation in Peritoneal Dialysis and the Effect of Low Glucose Plus Amino Acid Solutions. Perit Dial Int. 2018 Mar-Apr;38(2):149-152.
  37. Kalim S, Wald R, Yan AT, Goldstein MB, Kiaii M, Xu D, Berg AH, Clish C, Thadhani R, Rhee EP, Perl J. Extended Duration Nocturnal Hemodialysis and Changes in Plasma Metabolite Profiles. Clin J Am Soc Nephrol. 2018 Mar 7;13(3):436-444. PMCID: PMC5967674.
  38. Dobry AS, Ko LN, St John J, Sloan JM, Nigwekar S, Kroshinsky D. Association Between Hypercoagulable Conditions and Calciphylaxis in Patients With Renal Disease: A Case-Control Study. JAMA Dermatol. 2018 Feb 1;154(2):182-187. PMCID: PMC5839276.
  39. St John J, Vedak P, Garza-Mayers AC, Hoang MP, Nigwekar SU, Kroshinsky D. Location of skin lesions in Henoch-Schönlein purpura and its association with significant renal involvement. J Am Acad Dermatol. 2018 Jan;78(1):115-120.
  40. Allegretti AS, Parada XV, Eneanya ND, Gilligan H, Xu D, Zhao S, Dienstag JL, Chung RT, Thadhani RI. Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT. Clin J Am Soc Nephrol. 2018 Jan 6;13(1):16-25. PMCID: PMC5753306.
  41. Davis MI, Chute DF, Chung RT, Sise ME. When and how can nephrologists treat hepatitis C virus infection in dialysis patients? Semin Dial. 2018 Jan;31(1):26-36.
2017
  1. Zheng K, Wang H, Hou B, You H, Yuan J, Luo K, Chen L, Li M, Xu Q, Zhu Y, Cui L, Nigwekar SU, Feng F, Li X. Malnutrition-inflammation is a risk factor for cerebral small vessel diseases and cognitive decline in peritoneal dialysis patients: a cross-sectional observational study. BMC Nephrol. 2017 Dec 20;18(1):366. PMCID: PMC5738894.
  2. Allegretti AS, Parada XV, Eneanya ND, Gilligan H, Xu D, Zhao S, Dienstag JL, Chung RT, Thadhani RI. Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT. Clin J Am Soc Nephrol. 2017 Nov 9.
  3. Nigwekar SU, Weiser JM, Kalim S, Xu D, Wibecan JL, Dougherty SM, Mercier-Lafond L, Corapi KM, Eneanya ND, Holbrook EH, Brown D, Thadhani RI, Păunescu TG. Characterization and Correction of Olfactory Deficits in Kidney Disease. J Am Soc Nephrol. 2017 Nov;28(11):3395-3403. PMCID: PMC5661283
  4. Tonelli M, Wiebe N, Bello A, Field CJ, Gill JS, Hemmelgarn BR, Holmes DT, Jindal K, Klarenbach SW, Manns BJ, Thadhani R, Kinniburgh D; Alberta Kidney Disease Network. Concentrations of Trace Elements in Hemodialysis Patients: A Prospective Cohort Study. Am J Kidney Dis. 2017 Nov;70(5):696-704.
  5. Nigwekar SU, Jiramongkolchai P, Wunderer F, Bloch E, Ichinose R, Nazarian RM, Thadhani RI, Malhotra R, Bloch DB. Increased Bone Morphogenetic Protein Signaling in the Cutaneous Vasculature of Patients with Calciphylaxis. Am J Nephrol. 2017;46(5):429-438.
  6. Sise ME, Backman E, Ortiz GA, Hundemer GL, Ufere NN, Chute DF, Brancale J, Xu D, Wisocky J, Lin MV, Kim AY, Thadhani R, Chung RT. Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD. Clin J Am Soc Nephrol. 2017 Sep 7. pii: CJN.02510317.
  7. Parikh A, Rizzo JA, Canetta P, Forster C, Sise M, Maarouf O, Singer E, Elger A, Elitok S, Schmidt-Ott K, Barasch J, Nickolas TL. Correction: Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis. PLoS One. 2017 Sep 27;12(9):e0185772. PMCID: PMC5617218.
  8. Griessenauer CJ, Chua MH, Hanafy KA, Baffour YT, Chen R, LeBlanc RH 3rd, Patel AS, Salem M, Karumanchi SA, Xu D, Thadhani R, Ogilvy CS, Thomas AJ. Soluble Fms-like tyrosine kinase-1 (sFlt-1) and risk of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2017 Aug 31. pii: S1878-8750(17)31429-8.
  9. Smith WB, Gibson S, Newman GE, Hendon KS, Askelson M, Zhao J, Hantash J, Flanagan B, Larkin JW, Usvyat LA, Thadhani RI, Maddux FW. The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: a phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation. BMC Nephrology (2017) 18:273. PMCID: PMC5576126
  10. Khedkar SA, Samad MA, Choudhury S, Lee JY, Zhang D, Thadhani RI, Karumanchi SA, Rigby AC, Kang PM. Identification of Novel Non-secosteroidal Vitamin D Receptor Agonists with Potent Cardioprotective Effects and devoid of Hypercalcemia. Sci Rep. 2017 Aug 16;7(1):8427. PMCID: PMC5559458
  11. Berg AH, Bhan I, Powe C, Karumanchi SA, Xu D, Thadhani RI. Acute Homeostatic Changes Following Vitamin D2 Supplementation. J Endocr Soc. 2017 Jul 19;1(9):1135-1149. PMCID: PMC5686571
  12. Fan X, Kalim S, Ye W, Zhao S, Ma J, Nigwekar SU, Chan KE, Cui J, Cai J, Wang L, Heng W, Zhou Y, Sun Y, Cui R, Zhang W, Wang B, Dai Q, Li X, Thadhani R, Li X. Urinary Stone Disease and Cardiovascular Disease Risk in a Rural Chinese Population. Kidney Int Rep. 2017 Jun 8;2(6):1042-1049. PMCID: PMC5733875.
  13. Nigwekar SU, Jiramongkolchai P, Wunderer F, Bloch E, Ichinose R, Nazarian RM, Thadhani RI, Malhotra R, Bloch DB. Increased Bone Morphogenetic Protein Signaling in the Cutaneous Vasculature of Patients with Calciphylaxis. Am J Nephrol. 2017;46(5):429-438. PMCID: PMC5763243.
  14. Nigwekar SU, Bloch DB, Nazarian RM, Vermeer C, Booth SL, Xu D, Thadhani RI, Malhotra R. Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis. J Am Soc Nephrol. 2017 Jun;28(6):1717-1722. PMCID: PMC5461787
  15. Lim K, Steele D, Fenves A, Thadhani R, Heher E, Karaa A. Focal segmental glomerulosclerosis associated with mitochondrial disease. Clin Nephrol Case Stud. 2017 Mar 3;5:20-25. PMCID: PMC5438005
  16. Tangren JS, Powe CE, Ankers E, Ecker J, Bramham K, Hladunewich MA, Karumanchi SA, Thadhani R. Pregnancy Outcomes after Clinical Recovery from AKI. J Am Soc Nephrol. 2017 May;28(5):1566-1574. PMCID: PMC5407730
  17. Lim K, Heher E, Steele D, Fenves AZ, Tucker JK, Thadhani R, Christopher K, Tolkoff-Rubin N. Hemodialysis failure secondary to hydroxocobalamin exposure. Proc (Bayl Univ Med Cent). 2017 Apr;30(2):167-168. PMCID: PMC5349814
  18. Goldsmith D, Thadhani RI. Low Sodium Diet, Vitamin D, or Both for RAASi-Resistant, Residual, Proteinuria in CKD? The ViRTUE Trial Points the Way Forward but Is Not the Last Word. J Am Soc Nephrol. 2017 Apr;28(4):1016-1019. PMCID: PMC5373469
  19. Hagmann H, Thadhani RI. Angiogenic Markers in Transition: Thinking Positive. Hypertension. 2017 Apr;69(4):578-579.
  20. Torino C, Pizzini P, Cutrupi S, Tripepi G, Mallamaci F, Thadhani R, Zoccali C. Active vitamin D treatment in CKD patients raises serum sclerostin and this effect is modified by circulating pentosidine levels. Nutr Metab Cardiovasc Dis. 2017 Mar;27(3):260-266.
  21. Balekian DS, Linnemann RW, Hasegawa K, Thadhani R, Camargo CA Jr. Cohort Study of Severe Bronchiolitis during Infancy and Risk of Asthma by Age 5 Years. J Allergy Clin Immunol Pract. 2017 Jan – Feb;5(1):92-96.
  22. Bikle D, Bouillon R, Thadhani R, Schoenmakers I. Vitamin D metabolites in captivity? Should we measure free or total 25(OH)D to assess vitamin D status? J Steroid Biochem Mol Biol. 2017 Jan 16.
2016
  1. DuBrock HM, Rodriguez-Lopez JM, LeVarge BL, Curry MP, VanderLaan PA, Zsengeller ZK, Pernicone E, Preston IR, Yu PB, Nikolic I, Xu D, Thadhani RI, Channick RN, Ananth Karumanchi S. Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension. Pulm Circ. 2016 Dec;6(4):498-507. PMCID: PMC5210057
  2. Watkins BA, Kim J, Tamez H, Wenger J, Thadhani R, Friedman AN. Serum phospholipid fraction of polyunsaturated fatty acids is the preferred indicator for nutrition and health status in hemodialysis patients. J Nutr Biochem. 2016 Dec 26;38:18-24.
  3. Allegretti AS, Ortiz G, Kalim S, Wibecan J, Zhang D, Shan HY, Xu D, Chung RT, Karumanchi SA, Thadhani RI. Siglec-7 as a novel biomarker to predict mortality in decompensated cirrhosis and acute kidney injury. Dig Dis Sci. 2016 Dec;61(12):3609-3620. PMCID: PMC5106324.
  4. Thadhani R, Zella JB, Knutson DC, Blaser WJ, Plum LA, Clagett-Dame M, Buck RD, DeLuca HF. 2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized Trial. Am J Nephrol. 2016 Nov 24;45(1):40-48.
  5. Sircar M, Kotton C, Wojciechowski D, Safa K, Gilligan H, Heher E, Williams W, Thadhani R, Tolkoff-Rubin N. Voriconazole-Induced Periostitis & Enthesopathy in Solid Organ Transplant Patients: Case Reports. J Biosci Med (Irvine). 2016 Nov;4(11):8-17. PMCID: PMC5158005.
  6. Nigwekar SU, Zhao S, Wenger J, Hymes JL, Maddux FW, Thadhani RI, Chan KE. A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors. J Am Soc Nephrol. 2016 Nov;27(11):3421-3429. PMCID: PMC5084892.
  7. Cavalli RC, Cerdeira AS, Pernicone E, Korkes HA, Burke SD, Rajakumar A, Thadhani RI, Roberts DJ, Bhasin M, Karumanchi SA, Kopcow HD. Induced Human Decidual NK-Like Cells Improve Utero-Placental Perfusion in Mice. PLoS One. 2016 Oct 13;11(10):e0164353.
  8. Nadkarni NA, Rajakumar A, Mokhashi N, Burke SD, Rana S, Salahuddin S, Dang Q, Thadhani R, Krishnan R, Stossel TP, Karumanchi SA. Gelsolin is an endogenous inhibitor of syncytiotrophoblast extracellular vesicle shedding in pregnancy. Pregnancy Hypertens. 2016 Oct;6(4):333-339.
  9. Ayus JC, Fuentes NA, Negri AL, Moritz ML, Giunta DH, Kalantar-Zadeh K, Nigwekar SU, Thadhani RI, Go AS, De Quiros FG. Mild prolonged chronic hyponatremia and risk of hip fracture in the elderly. Nephrol Dial Transplant. 2016 Oct;31(10):1662-9.
  10. Perl J, Kalim S, Wald R, Goldstein MB, Yan AT, Noori N, Kiaii M, Wenger J, Chan C, Thadhani RI, Karumanchi SA, Berg AH. Reduction of carbamylated albumin by extended hemodialysis. Hemodial Int. 2016 Oct;20(4):510-521.
  11. Sise ME, Wisocky J, Rosales IA, Chute D, Holmes JA, Corapi KM, Babitt JL, Tangren JS, Hashemi N, Lundquist AL, Williams WW, Mount DB, Andersson KL, Rennke HG, Smith RN, Colvin R, Thadhani RI, Chung RT. Lupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy. KI Rep. 2016 Sep;1(3):135-143. PMCID: PMC5155703.
  12. Zhang Y, Corapi KM, Luongo M, Thadhani R, Nigwekar SU. Calciphylaxis in peritoneal dialysis patients: a single center cohort study. Int J Nephrol Renovasc Dis. 2016 Sep 19;9:235-241. PMCID: PMC5034913
  13. Kalim S, Trottier CA, Wenger JB, Wibecan J, Ahmed R, Ankers E, Karumanchi SA, Thadhani R, Berg AH. Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis. Clin J Am Soc Nephrol. 2016 Jul 21. PMCID: PMC5053789
  14. Eneanya ND, Wenger JB, Waite K, Crittenden S, Hazar DB, Volandes A, Temel JS, Thadhani R, Paasche-Orlow MK. Racial Disparities in End-of-Life Communication and Preferences among Chronic Kidney Disease Patients. Am J Nephrol. 2016;44(1):46-53. PMCID: PMC4961563
  15. Zoccali C, Torino C, Curatola G, Panuccio V, Tripepi R, Pizzini P, Versace M, Bolignano D, Cutrupi S, Ghiadoni L, Thadhani R, Tripepi G, Mallamaci F. Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patients. Nutr Metab Cardiovasc Dis. 2016 Jul;26(7):581-9.
  16. Baltajian K, Bajracharya S, Salahuddin S, Berg AH, Geahchan C, Wenger JB, Thadhani R, Karumanchi SA, Rana S. Sequential Plasma Angiogenic Factors Levels in Women with Suspected Preeclampsia. Am J Obstet Gynecol. 2016 Jul;215(1):89.e1-89.e10.
  17. Chait Y, Kalim S, Horowitz J, Hollot CV, Ankers ED, Germain MJ, Thadhani RI. The greatly misunderstood erythropoietin resistance index and the case for a new responsiveness measure. Hemodial Int. 2016 Jul;20(3):392-8. PMCID: PMC4934130
  18. Powe CE, Allard C, Battista MC, Doyon M, Bouchard L, Ecker JL, Perron P, Florez JC, Thadhani R, Hivert MF. Heterogeneous Contribution of Insulin Sensitivity and Secretion Defects to Gestational Diabetes Mellitus. Diabetes Care. 2016 Jun;39(6):1052-5. PMCID: PMC4878218
  19. Shahul S, Medvedofsky D, Wenger JB, Nizamuddin J, Brown SM, Bajracharya S, Salahuddin S,Thadhani R, Mueller A, Tung A, Lang RM, Arany Z, Talmor D, Karumanchi SA, Rana S. Circulating Antiangiogenic Factors and Myocardial Dysfunction in Hypertensive Disorders of Pregnancy. Hypertension. 2016 Jun;67(6):1273-80.
  20. Makris A, Yeung KR, Lim SM, Sunderland N, Heffernan S, Thompson JF, Iliopoulos J, Killingsworth MC, Yong J, Xu B, Ogle RF, Thadhani R, Karumanchi SA, Hennessy A. Placental Growth Factor Reduces Blood Pressure in a Uteroplacental Ischemia Model of Preeclampsia in Nonhuman Primates. Hypertension. 2016 Jun;67(6):1263-72. PMCID: PMC4867111
  21. Salahuddin S, Wenger JB, Zhang D, Thadhani R, Karumanchi SA, Rana S. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes. Hypertens Pregnancy. 2016 Aug;35(3):330-45.
  22. Allegretti AS, Ortiz G, Cui J, Wenger J, Bhan I, Chung RT, Thadhani RI, Irani Z. Changes in Kidney Function After Transjugular Intrahepatic Portosystemic Shunts Versus Large-Volume Paracentesis in Cirrhosis: A Matched Cohort Analysis. Am J Kidney Dis. 2016 Sep;68(3):381-91. PMCID: PMC5002241
  23. Thadhani R, Hagmann H, Schaarschmidt W, Roth B, Cingoez T, Karumanchi SA, Wenger J, Lucchesi KJ, Tamez H, Lindner T, Fridman A, Thome U, Kribs A, Danner M, Hamacher S, Mallmann P, Stepan H, Benzing T. Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia. J Am Soc Nephrol. 2016 Mar;27(3):903-13. PMCID: PMC4769204
  24. Tonelli M, Karumanchi SA, Thadhani R. Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease.Circulation. 2016 Feb 2;133(5):518-36.
  25. Balekian DS, Linnemann RW, Castro VM, Perlis R, Thadhani R, Camargo CA Jr. Pre-birth cohort study of atopic dermatitis and severe bronchiolitis during infancy. Pediatr Allergy Immunol. 2016 Jun;27(4):413-8.
  26. Sise ME, Bloom AK, Wisocky J, Lin MV, Gustafson JL, Lundquist AL, Steele D, Thiim M, Williams WW, Hashemi N, Kim AY, Thadhani R, Chung RT. Treatment of Hepatitis C Virus-Associated Mixed Cryoglobulinemia with Sofosbuvir-Based Direct-Acting Antiviral Agents. Hepatology. 2016 Feb;63(2):408-17. PMCID: PMC4718772
  27. Bentley-Lewis R, Huynh J, Li S, Wenger J, Thadhani R. Hypertension Risk Subsequent to Gestational Dysglycemia Is Modified by Race/Ethnicity. Hypertension. 2016 Jan;67(1):223-8. PMCID: PMC4827775
2015
  1. Goel A, Maski MR, Bajracharya S, Wenger JB, Zhang D, Salahuddin S, Shahul SS, Thadhani R, Seely EW, Karumanchi SA, Rana S. Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period. Circulation. 2015 Nov 3;132(18):1726-33. PMCID: PMC4816491
  2. Huynh J, Yamada J, Beauharnais C, Wenger JB, Thadhani RI, Wexler D, Roberts DJ, Bentley-Lewis R. Type 1, type 2 and gestational diabetes mellitus differentially impact placental pathologic characteristics of uteroplacental malperfusion. Placenta. 2015 Aug 12. pii: S0143-4004(15)30031-X. PMCID: PMC4609602
  3. Allegretti AS, Ortiz G, Wenger J, Deferio JJ, Wibecan J, Kalim S, Tamez H, Chung RT, Karumanchi SA, Thadhani RI. Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study. Int J Nephrol. 2015;2015:108139. PMCID: PMC4525763
  4. Samir AE, Allegretti AS, Zhu Q, Dhyani M, Anvari A, Sullivan DA, Trottier CA, Dougherty S, Williams WW, Babitt JL, Wenger J, Thadhani RI, Lin HY. Shear wave elastography in chronic kidney disease: a pilot experience in native kidneys. BMC Nephrol. 2015 Jul 31;16(1):119. PMCID: PMC4521488
  5. Kalim S, Clish CB, Deferio JJ, Ortiz G, Moffet AS, Gerszten RE, Thadhani R, Rhee EP. Cross-sectional examination of metabolites and metabolic phenotypes in uremia. BMC Nephrol. 2015 Jul 7;16:98. PMCID: PMC4491861
  6. Walmer R, Huynh J, Wenger J, Ankers E, Mantha AB, Ecker J, Thadhani R, Park E, Bentley-Lewis R. Mental Health Disorders Subsequent To Gestational Diabetes Mellitus Differ By Race/Ethnicity. Depress Anxiety. 2015 Jun 30.
  7. Bentley-Lewis R, Huynh J, Xiong G, Lee H, Wenger J, Clish C, Nathan D, Thadhani R, Gerszten R. Metabolomic profiling in the prediction of gestational diabetes mellitus. Diabetologia. 2015 Jun;58(6):1329-32. PMCID: PMC4428592
  8. March MI, Geahchan C, Wenger J, Raghuraman N, Berg A, Haddow H, Mckeon BA, Narcisse R, David JL, Scott J, Thadhani R, Karumanchi SA, Rana S. Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia. PLoS One. 2015 May 12;10(5):e0126815. PMCID: PMC4428697
  9. Nigwekar SU, Kroshinsky D, Nazarian RM, Goverman J, Malhotra R, Jackson VA, Kamdar MM, Steele DJ, Thadhani RI. Calciphylaxis: Risk Factors, Diagnosis, and Treatment. Am J Kidney Dis. 2015 Jul;66(1):133-46.
  10. Ruchi R, Genovese G, Lee J, Charoonratana VT, Bernhardy AJ, Alper SL, Kopp JB, Thadhani R, Friedman DJ, Pollak MR. Copy Number Variation at the APOL1 Locus. PLoS One. 2015 May 1;10(5):e0125410. PMCID: PMC4416782
  11. Sise ME, Backman ES, Wenger JB, Wood BR, Sax PE, Chung RT, Thadhani R, Kim AY. Short and long-term effects of telaprevir on kidney function in patients with hepatitis C virus infection: a retrospective cohort study. PLoS One. 2015 Apr 29;10(4):e0124139. PMCID: PMC4414554
  12. Palomaki GE, Haddow JE, Haddow HR, Salahuddin S, Geahchan C, Cerdeira AS, Verlohren S, Perschel FH, Horowitz G, Thadhani R, Karumanchi SA, Rana S. Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia. Prenat Diagn. 2015 Apr;35(4):386-93. PMCID: PMC4409832
  13. Cerdeira AS, Thadhani R. Editorial: “Interfering” with preeclampsia. Arthritis Rheumatol. 2015 Apr;67(4):862-4.
  14. Berg AH, Powe CE, Evans MK, Wenger JB, Ortiz G, Zonderman AB, Suntharalingam P, Lucchesi KJ, Powe NR, Karumanchi SA, Thadhani RI. 24,25-dihydroxyvitamin D3 and Vitamin D Status of Community Dwelling Black and White Americans. Clin Chem. 2015 Jun;61(6):877-84.
  15. Bhan I, Dobens D, Tamez H, Deferio JJ, Li YC, Warren HS, Ankers E, Wenger J, Tucker JK, Trottier C, Pathan F, Kalim S, Nigwekar SU, Thadhani R. Nutritional vitamin d supplementation in dialysis: a randomized trial. Clin J Am Soc Nephrol. 2015 Apr 7;10(4):611-9. PMCID: PMC4386253
  16. Kalim S, Ortiz G, Trottier CA, Deferio JJ, Karumanchi SA, Thadhani RI, Berg AH. The Effects of Parenteral Amino Acid Therapy on Protein Carbamylation in Maintenance Hemodialysis Patients. J Ren Nutr. 2015 Jul;25(4):388-92. PMCID: PMC446957
  17. Chan KE, Edelman ER, Wenger JB, Thadhani RI, Maddux FW. Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis. Circulation 2015 Mar 17;131(11):972-9. PMCID: PMC4363265
  18. Drechsler C, Kalim S, Wenger JB, Suntharalingam P, Hod T, Thadhani RI, Karumanchi SA, Wanner C, Berg AH. Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease. Kidney Int. 2015 Jun;87(6):1201-8. PMCID: PMC4449819
  19. Baltajian K, Hecht JL, Wenger JB, Salahuddin S, Verlohren S, Perschel FH, Zsengeller ZK, Thadhani R, Ananth Karumanchi S, Rana S. [56-OR]: Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia. Pregnancy Hypertens. 2015 Jan;5(1):28-9.
  20. Palomaki GE, Haddow JE, Haddow H, Salahuddin S, Geahchan C, Cerdeira AS, Verlohren S, Perschel FH, Horowitz G, Thadhani R, Karumanchi SA, Rana S. [24-OR]: Modeling risk for adverse outcomes in women with suspected preterm preeclampsia using angiogenic factor measurements. Pregnancy Hypertens. 2015 Jan;5(1):12.
  21. Humalda JK, Goldsmith DJ, Thadhani R, de Borst MH. Vitamin D analogues to target residual proteinuria: potential impact on cardiorenal outcomes. Nephrol Dial Transplant. 2015 Dec;30(12):1988-94. PMCID: PMC4832986
  22. Cui J, Kessinger C, McCarthy J, Sosnovik D, Libby P, Thadhani R, Jaffer F. In Vivo Nanoparticle Assessment of Pathological Endothelium Predicts the Development of Inflow Stenosis in Murine Arteriovenous Fistula. Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):189-96. PMCID: PMC4270948.
2014
  1. Chan KE, Thadhani R, Maddux FW. Adherence Barriers to Chronic Dialysis in The United States. J Am Soc Nephrol. 2014 Nov;25(11):2642-8 PMID: 24762400 PMCID: PMC4214530
  2. Zoccali C, Curatola G, Panuccio V, Tripepi R, Pizzini P, Versace M, Bolignano D, Cutrupi S, Politi R, Tripepi G, Ghiadoni L, Thadhani R, Mallamaci F. Paricalcitol and Endothelial Function in Chronic Kidney Disease Trial. Hypertension. 2014 Nov;64(5):1005-11. PMID: 25259743
  3. Baltajian K, Hecht JL, Wenger JB, Salahuddin S, Verlohren S, Perschel FH, Zsengeller ZK, Thadhani R, Karumanchi SA, Rana S. Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia. Hypertens Pregnancy. 2014 Nov;33(4):427-39. PMID: 25062083
  4. Kalim S, Karumanchi SA, Thadhani RI, Berg AH. Protein carbamylation in kidney disease: pathogenesis and clinical implications. Am J Kidney Dis. 2014 Nov;64(5):793-803. PMID: 25037561 PMCID: PMC4209336
  5. Nigwekar SU, Solid CA, Ankers E, Malhotra R, Eggert W, Turchin A, Thadhani RI, Herzog CA. Quantifying a Rare Disease in Administrative Data: The Example of Calciphylaxis. J Gen Intern Med. 2014 Aug;29 Suppl 3:S724-31 PMID: 25029979 PMCID: PMC4124115
  6. Scott MG, Gronowski AM, Reid IR, Holick MF, Thadhani R, Phinney K. Vitamin D: The More We Know, the Less We Know. Clin Chem. 2014 Jul 23. pii: clinchem.2014.222521. PMID: 25056405
  7. Bentley-Lewis R, Powe C, Ankers E, Wenger J, Ecker J, Thadhani R. Effect of Race/Ethnicity on Hypertension Risk Subsequent to Gestational Diabetes Mellitus. Am J Cardiol. 2014 Apr 15;113(8):1364-70. PMID: 24576544 PMCID: PMC3994994
  8. Bentley-Lewis R, Dawson DL, Wenger JB, Thadhani RI, Roberts DJ. Placental histomorphometry in gestational diabetes mellitus: the relationship between subsequent type 2 diabetes mellitus and race/ethnicity. Am J Clin Pathol. 2014 Apr;141(4):587-92. PMID:24619761 PMCID: PMC4040002
  9. Welles CC, Whooley MA, Karumanchi SA, Hod T, Thadhani R, Berg AH, Ix JH, Mukamal KJ. Vitamin D Deficiency and Cardiovascular Events in Patients With Coronary Heart Disease: Data From the Heart and Soul Study. Am J Epidemiol. 2014 Jun 1;179(11):1291-2 PMID: 24699783 PMCID: PMC4036212
  10. Welles CC, Whooley MA, Karumanchi SA, Hod T, Thadhani R, Berg AH, Ix JH, Mukamal KJ. Welles et al. Respond to “Low Vitamin D and Cardiovascular Disease”. Am J Epidemiol. 2014 Jun 1;179(11):1291-2 PMID: 24699785 PMCID: PMC4036211
  11. Powe CE, Karumanchi SA, Thadhani R. Vitamin D-binding protein and vitamin D in blacks and whites. N Engl J Med. 2014 Feb 27;370(9):880-1. PMID: 24571762
  12. Nigwekar SU, Tamez H, Thadhani RI. Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD). Bonekey Rep. 2014 Feb 5;3:498. eCollection 2014. Review. PMID:24605215 PMCID: PMC3944129
  13. Cohen AL, Wenger JB, James-Todd T, Lamparello BM, Halprin E, Serdy S, Fan S, Horowitz GL, Lim KH, Rana S, Takoudes TC, Wyckoff JA, Thadhani R, Karumanchi SA, Brown FM. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertens Pregnancy. 2014 Feb;33(1):81-92. PMID: 24354578 PMCID: PMC3894714
  14. Hagmann H, Bossung V, Belaidi AA, Fridman A, Karumanchi SA, Thadhani R, Schermer B, Mallmann P, Schwarz G, Benzing T, Brinkkoetter PT. Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination. PLoS One. 2014 Jan 21;9(1):e85258. PMID: 24465515 PMCID: PMC3897409
2013
  1. Nigwekar SU, Thadhani R. Vitamin D receptor activation: cardiovascular and renal implications. Kidney Int Suppl (2011). 2013 Dec;3(5):427-430. PMID:25019025 PMCID: PMC4089580
  2. Kalim S, Clish CB, Wenger J, Elmariah S, Yeh RW, Deferio JJ, Pierce K, Deik A, Gerszten RE, Thadhani R, Rhee EP. A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients. J Am Heart Assoc. 2013 Dec 5;2(6):e000542. PMID: 24308938 PMCID: PMC3886735
  3. Powe CE, Evans MK, Wenger J, Zonderman AB, Tamez H, Berg A, Bhan I, Karumanchi SA, Powe NR, Thadhani R. Vitamin D Binding Protein and Vitamin D Status in White and Black Americans. N Eng J Med 2013 Nov 21;369(21):1991-2000. PMID: 24256378 PMCID: PMC4030388
  4. Kong J, Zhu X, Shi Y, Liu T, Chen Y, Bhan I, Zhao Q, Thadhani R, Li YC. VDR Attenuates Acute Lung Injury by Blocking Ang-2-Tie-2 Pathway and Renin-Angiotensin System. Mol Endocrinol. 2013 Dec;27(12):2116-25 PMID: 24196349 PMCID: PMC3857197
  5. Thadhani RI, Manson JE. Vitamin d: too soon to turn out the lights? Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):2467-9. PMID: 24132745
  6. de Boer IH, Thadhani R. Vitamin D Deficiency: Consequence or Cause of CKD? Clin J Am Soc Nephrol. 2013 Nov;8(11):1844-6 PMID: 24135217 PMCID: PMC3817913
  7. Moe SM, Thadhani R. What have we learned about chronic kidney disease-mineral bone disorder from the EVOLVE and PRIMO trials? Curr Opin Nephrol Hypertens. 2013 Nov;22(6):651-655. PMID:24100218 PMCID: PMC3983668
  8. Li YC, Chen Y, Liu W, Thadhani R. MicroRNA-mediated mechanism of vitamin D regulation of innate immune response. J Steroid Biochem Mol Biol. 2013 Oct 5. pii: S0960-0760(13)00188-X. PMID:24103701 PMCID: PMC3976893
  9. Gunta SS, Thadhani RI, Mak RH. The effect of vitamin D status on risk factors for cardiovascular disease. Nat Rev Nephrol. 2013 Oct 1. [Epub ahead of print] PMID:24080800
  10. Panizo S, Barrio-Vázquez S, Naves-Díaz M, Carrillo-López N, Rodríguez I, Fernández-Vázquez A, Valdivielso JM, Thadhani R, Cannata-Andía JB. Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis. Nephrol Dial Transplant. 2013 Nov;28(11):2735-44 PMID: 24013683
  11. Kalim S, Tamez H, Wenger J, Ankers E, Trottier CA, Deferio JJ, Berg AH, Karumanchi SA, Thadhani RI. Carbamylation of Serum Albumin and Erythropoietin Resistance in End Stage Kidney Disease. Clin J Am Soc Nephrol. 2013 Nov;8(11):1927-34 PMID: 23970130 PMCID: PMC3817911
  12. de Borst MH, Hajhosseiny R, Tamez H, Wenger J, Thadhani R, Goldsmith DJ. Active Vitamin D Treatment for Reduction of Residual Proteinuria: A Systematic Review. J Am Soc Nephrol. 2013 Nov;24(11):1863-71 PMID: 23929770 PMCID: PMC3810088
  13. Bello AK, Stenvinkel P, Lin M, Hemmelgarn B, Thadhani R, Klarenbach S, Chan C, Zimmerman D, Cembrowski G, Strippoli G, Carrero JJ, Tonelli M. Serum Testosterone Levels and Clinical Outcomes in Male Hemodialysis Patients. Am J Kidney Dis. 2013 Jul 26. [Epub ahead of print] PMID: 23896484
  14. Cruz DN, Bagshaw SM, Maisel A, Lewington A, Thadhani R, Chakravarthi R, Murray PT, Mehta RL, Chawla LS. Use of Biomarkers to Assess Prognosis and Guide Management of Patients with Acute Kidney Injury. Contrib Nephrol. 2013;182:45-64. PMID:23689655
  15. McCullough PA, Bouchard J, Waikar SS, Siew ED, Endre ZH, Goldstein SL, Koyner JL, Macedo E, Doi K, Di Somma S, Lewington A, Thadhani R, Chakravarthi R, Ice C, Okusa MD, Duranteau J, Doran P, Yang L, Jaber BL, Meehan S, Kellum JA, Haase M, Murray PT, Cruz D, Maisel A, Bagshaw SM, Chawla LS, Mehta RL, Shaw AD, Ronco C. Implementation of Novel Biomarkers in the Diagnosis, Prognosis, and Management of Acute Kidney Injury: Executive Summary from the Tenth Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2013;182:5-12. PMID:23689652 PMCID: PMC3856225
  16. Bhan I, Tamez H, Thadhani R. Impact of new Vitamin D data on future studies and treatment. Curr Opin Nephrol Hypertens. 2013 Jul;22(4):377-82. PMID: 23666416 PMCID: PMC3984907
  17. Friedman AN, Yu Z, Denski C, Tamez H, Wenger J, Thadhani R, Li Y, Watkins B. Fatty Acids and Other Risk Factors for Sudden Cardiac Death in Patients Starting Hemodialysis. Am J Nephrol. 2013 Jun 25;38(1):12-18. PMID:23816975 PMCID: PMC3856432
  18. Block GA, Ix JH, Ketteler M, Martin KJ, Thadhani RI, Tonelli M, Wolf M, Juppner H, Hruska K, Wheeler DC. Phosphate Homeostasis in CKD: Report of a Scientific Symposium Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2013 Sep;62(3):457-73. PMID:23763855
  19. Friedman AN, Yu Z, Tabbey R, Denski C, Tamez H, Wenger J, Thadhani R, Li Y, Watkins BA. Inverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysis. Kidney Int. 2013 Jun;83(6):1130-5. PMID: 23389417 PMCID: PMC3655118
  20. Gunta SS, Thadhani RI, Mak RH. The effect of vitamin D status on risk factors for cardiovascular disease. Nat Rev Nephrol. 2013 Jun;9(6):337-47. PMID: 23609564
  21. Rana S, Schnettler WT, Powe C, Wenger J, Salahuddin S, Cerdeira AS, Verlohren S, Perschel FH, Arany Z, Lim KH, Thadhani R, Karumanchi SA. Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy. 2013 May;32(2):189-201. PMID:23725084 PMCID: PMC3744824
  22. Chan KE, Thadhani RI, Maddux FW. No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease. Kidney Int. 2013 Sep;84(3):555-61 PMID:23677243
  23. Tamez H, Andress D, Solomon SD, Thadhani R. Reply to “The role of fibroblast growth factor-23 in left atrial volume”. Am Heart J. 2013 May;165(5):e23. PMID: 23622924
  24. Cerdeira AS, Rajakumar A, Royle CM, Lo A, Husain Z, Thadhani RI, Sukhatme VP, Karumanchi SA, Kopcow HD. Conversion of Peripheral Blood NK Cells to a Decidual NK-like Phenotype by a Cocktail of Defined Factors. J Immunol. 2013 Apr 15;190(8):3939-48. PMID: 23487420 PMCID: PMC3742368
  25. Nigwekar SU, Wenger J, Thadhani RI, Bhan I. Hyponatremia, Mineral Metabolism, and Mortality in Incident Maintenance Hemodialysis Patients: A Cohort Study. Am J Kidney Dis. 2013 Oct:62(4):755-62 PMID: 23591291 PMCID: PMC3972035
  26. Chen Y, Liu W, Sun T, Huang Y, Wang Y, Deb DK, Yoon D, Kong J, Thadhani R, Li YC. 1,25-Dihydroxyvitamin D Promotes Negative Feedback Regulation of TLR Signaling via Targeting MicroRNA-155-SOCS1 in Macrophages. J Immunol. 2013 Apr 1;190(7):3687-95. PMID: 23436936 PMCID: PMC3608760
  27. Bhan I, Thadhani R. Fibroblast Growth Factor-23 and Outcomes: New Answers, New Questions. J Am Soc Nephrol. 2013 Mar;24(4):523-5. PMID: 23520207
  28. Tamez H, Kalim S, Thadhani RI. Does vitamin D modulate blood pressure? Curr Opin Nephrol Hypertens. 2013 Mar;22(2):204-9. PMID: 23299053 PMCID: PMC3984388
  29. Nigwekar SU, Bhan I, Turchin A, Skentzos S, Hajhosseiny R, Steele D, Nazarian RM, Wenger J, Parikh S, Karumanchi SA, Thadhani RI. Statin Use and Calcific Uremic Arteriolopathy: A Matched Case-Control Study. Am J Nephrol 2013 Mar 21;37(4):325-332. PMID: 23548843 PMCID: PMC4110510
  30. Berg AH, Drechsler C, Wenger J, Buccafusca R, Hod T, Kalim S, Ramma W, Parikh SM, Friedman DJ, Danziger J, Wanner C, Thadhani R, Karumanchi SA. Carbamylation of Serum Albumin as a Risk Factor for Mortality in Patients with Kidney Failure. Sci Transl Med. 2013 Mar 6;5(175):175ra29. PMID: 23467560 PMCID: PMC3697767
  31. Nigwekar SU, Thadhani RI. Shining light on vitamin D trials in chronic kidney disease. Kidney Int. 2013 Feb;83(2):198-200. PMID: 23364588 PMCID: PMC3991009
2012
  1. Tamez H, Zoccali C, Packham D, Wenger J, Bhan I, Appelbaum E, Pritchett Y, Chang Y, Agarwal R, Wanner C, Lloyd-Jones D, Cannata J, Thompson BT, Andress D, Zhang W, Singh B, Zehnder D, Pachika A, Manning WJ, Shah A, Solomon SD, Thadhani R. Vitamin D Reduces Left Atrial Volume in Patients with Left Ventricular Hypertrophy and Chronic Kidney Disease. Am Heart J. 2012 Dec;164(6):902-909.e2. PMID: 23194491
  2. Vikse BE, Irgens LM, Karumanchi SA, Thadhani R, Reisaeter AV, Skjaerven R. Familial Factors in the Association between Pre-Eclampsia and Later ESRD. Clin J Am Soc Nephrol. 2012 Nov;7(11):1819-26. PMID: 22956264 PMCID: PMC3488941
  3. Friedman AN, Yu Z, Tabbey R, Denski C, Tamez H, Wenger J, Thadhani R, Li Y, Watkins BA. Low Blood Levels of Long Chain n-3 Polyunsaturated Fatty Acids in U.S. Hemodialysis Patients. Am J Nephrol. 2012;36(5):451-8. PMID: 23128302 PMCID: PMC3784309
  4. Rana S, Ceideira AS, Wenger J, Salahuddin S, Lim KH, Ralston SJ, Thadhani RI, Karumanchi SA. Plasma Concentrations of Soluble Endoglin versus Standard Evaluation in Patients with Suspected Preeclampsia. PLoS One. 2012;7(10):e48259. PMID: 23110221 PMCID: PMC3482204
  5. Chan KE, Warren HS, Thadhani RI, Steele DJ, Hymes JL, Maddux FW, Hakim RM. Prevalence and Outcomes of Antimicrobial Treatment for Staphylococcus Aureus Bloodstream Infection in Outpatients with End-Stage Renal Disease; J Am Soc Nephrol 2012 Sep;23(9):1551-9. PMID: 22904350 PMCID: PMC3431413
  6. Tamez H, Thadhani RI. Vitamin D and Hypertension: an update and review; Curr Opin Nephrol Hypertens. 2012 Sep;21(5):492-9. PMID: 22820371
  7. Szeto FL, Reardon CA, Yoon D, Wang Y, Wong KE, Chen Y, Kong J, Liu SQ, Thadhani R, Getz GS, Li YC. Vitamin D Receptor Signaling Inhibits Atherosclerosis in Mice; Mol Endocrinol. 2012 Jul;26(7):1091-101. PMID: 22638071 PMCID: PMC3385794
  8. Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, Kooienga L, Thadhani R, Mannstadt M, Wolf M, Chertow GM. Effects of Phosphate Binders in Moderate CKD; J Am Soc Nephrol. 2012 Jul 19. PMID: 22822075 PMCID: PMC3402292
  9. Nigwekar SU, Bhan I, Thadhani R. Ergocalciferol and Cholecalciferol in CKD. Am J Kidney Dis. 2012 Jul;60(1):139-56 PMID: 22560832
  10. Bhan I, Powe CE, Berg AH, Ankers E, Wenger J, Karumanchi SA, Thadhani R. Bioavailable Vitamin D More Tightly Linked to Mineral Metabolism than Total Vitamin D in Dialysis. Kidney Int. 2012 Jul;82(1):84-9. PMID: 22398410 PMCID: PMC3376220
  11. Thadhani R, Tamez H, Solomon SD. Vitamin D Therapy and Cardiac Function In Chronic Kidney Disease; JAMA. 2012 Jun 6;307(21):2253.
  12. Hagmann H, Thadhani R, Benzing T, Karumanchi SA, Stepan H. The Promise of Angiogenic Markers for the Early Diagnosis and Prediction of Preeclampsia. Clin Chem. 2012 May;58(5):837-45. PMID: 22431894
  13. Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, Lim KH, Wenger JB, Thadhani R, Karumanchi SA. Angiogenic Factors and the Risk of Adverse Outcomes in Women with Suspected Preeclampsia. Circulation. 2012 Feb 21;125(7):911-9. PMID: 22261192 PMCID: PMC3319742
  14. Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H, Bhan I, Agarwal R, Zoccali C, Wanner C, Lloyd-Jones D, Cannata J, Thompson B, Andress D, Zhang W, Packham D, Singh B, Zehnder D, Shah A, Pachika A, Manning W, Solomon S. Vitamin D Therapy and Cardiac Structure and Function in Patients with Chronic Kidney Disease; The PRIMO Randomized Clinical Trial. JAMA. 2012 Feb 15;307(7):674-84. PMID: 22337679
  15. Melamed ML, Thadhani RI. Vitamin D Therapy in Chronic Kidney Disease and End Stage Renal Disease. Clin J Am Soc Nephrol. 2012 Feb;7(2):358-65. PMID: 22193236 PMCID: PMC3280034
2011
  1. Choi JH, Ke Q, Bae S, Lee JY, Kim YJ, Kim UK, Arbeeny C, Thadhani R, Kang PM. Doxercalciferol, a Pro-hormone of Vitamin D, Prevents the Development of Cardiac Hypertrophy in Rats. J Card Fail. 2011 Dec;17(12):1051-8. PMID: 22123370 PMCID: PMC3226953
  2. Faupel-Badger JM, Staff AC, Thadhani R, Powe CE, Potischman N, Hoover RN, Troisi R. Maternal Angiogenic Profile in Pregnancies That Remain Normotensive. Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):189-93. PMID: 21641103 PMCID: PMC3302581
  3. Kanji Z, Powe CE, Wenger JB, Huang C, Ankers E, Sullivan DA, Collerone G, Powe NR, Tonelli M, Bhan I, Friedman D, Bernhardy A,Genovese G, Pollak M, Thadhani R. Genetic Variation in APOL1 and Age at Hemodialysis Initiation in African Americans. J Am Soc Nephrol 2011 Oct 13. PMID: 21997398 PMCID: PMC3231784
  4. Boger CA, Gorski M, Li M, Hoffmann MM, Huang C, Yang Q, Teumer A, Krane V, O Seaghdha CM, Kutalik Z, Wichmann HE, Haak T, Boes E, Coassin S, Coresh J, Kollerits B, Haun M, Paulweber B, Kottgen A, Li G, Shlipak MG, Powe N, Hwang SJ, Dehghan A, Rivadeneira F, Uitterlinden A, Hofman A, Beckmann JS, Kramer BK, Witteman J, Bochud M, Siscovick D, Rettig R, Kronenberg F, Wanner C, Thadhani RI, Heid IM, Fox CS, Kao WH; The CKDGen Consortium. Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD. PLoS Genetics 2011 Sep:7(9):e1002292. PMID:21980298 PMCID: PMC3183079
  5. Chan KE, Maddux FW, Tolkoff-Rubin N, Karumanchi SA, Thadhani R, Hakim RM. Early Outcomes among Those Initiating Chronic Dialysis in the United States. Clin J Am Soc Nephrol. 2011 Sep 29. PMID: 21959599 PMCID: PMC3359565
  6. Rhee EP, Thadhani R. New insights into uremia-induced alterations in metabolic pathways. Curr Opin Nephrol Hypertens. 2011 Aug 31. PMID: 21885966
  7. Thadhani R, Kisner T, Hagmann H, Bossung V, Noack S, Schaarschmidt W, Jank A, Kribs A, Cornely OA, Kreyssig C, Hemphill L, Rigby AC, Khedkar S, Lindner TH, Mallmann P, Stepan S, Karumanchi SA, Benzing T. A pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 (sflt-1) in preeclampsia. Circulation Aug. 1 2011. PMID: 21810665
  8. Bae S, Yalamarti B, Ke Q, Choudhury S, Yu H, Karumanchi SA, Kroeger P, Thadhani R*, Kang PM*. (*Co-Senior Authors) Preventing Progression of Cardiac Hypertrophy and Development of Heart Failure by Paricalcitol Therapy in Rats. Cardiovascular Research 2011. Jun 2. PMID: 21565836 PMCID: PMC3156906
  9. Pritchett Y, Jemiai Y, Chang Y, Bhan I, Agarwal R, Zoccali C, Wanner C, Lloyd-Jones D, Cannata-Andia JB, Thompson T, Appelbaum E, Audhya P, Andress D, Zhang W, Solomon S, Manning WJ, Thadhani R. The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease. Clin Trials 2011;8(2):165-74. PMID: 21478328
  10. Powe CE, Ricciardi C, Berg AH, Erdenesanaa D, Collerone G, Ankers E, Wenger J, Karumanchi SA, Thadhani R, Bhan I. Vitamin D binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res. 2011 Jul;26(7):1609-16. PMID: 21416506. PMCID: PMC3351032
  11. Chen Y, Kong J, Sun T, Li George, Szeto FL, Liu W, Deb DK, Wang Y, Zhao Q, Thadhani R, Li YC. 1,25-Dihydroxyvitamin D3 Suppresses Inflammation-Induced Expression of Plasminogen Activator Inhibitor-1 by Blocking Nuclear Factor-kB Activation. Arch Biochem Biophys 2011 Mar 15;507(2):241-7. PMID: 21176770. PMCID: PMC3049452
  12. Powe CE, Ecker J, Rana S, Wang A, Ankers E, Ye J, Levine RJ, Karumanchi SA, Thadhani R. Preeclampsia and the risk of large-for-gestational-age infants. Am J Obstet Gynecol. 2011 May;204(5):425.e1-6. Epub 2011 Mar 3. PMID: 21371687
  13. Nigwekar SU, Bhan I, Thadhani R. Nutritional vitamin D in dialysis patients: what to D-iscern? Nephrol Dial Transplant. 2011 Mar;26(3):764-6. Epub 2011 Jan 13. PMID: 21239385
  14. Bello AK, Thadhani R, Hemmelgarn B, Klarenbach S, Gill J, Chan C, Zimmerman D, Holmes D, Cembrowski G, Opgenorth D, Sibrian R, Karkhaneh M, Tiv S, Wiebe N, Tonelli M. Design and implementation of the Canadian Kidney Disease Cohort Study (CKDCS): A prospective observational study of incident hemodialysis patients. BMC Nephrol. 2011;12:10. PMID: 21324196. PMCID: PMC3050805
  15. Bhan I, Camargo CA Jr, Wenger J, Ricciardi C, Ye J, Borregaard N, Thadhani R. Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adults. J Allergy Clin Immunol. 2011;127(5):1302-4.e1. PMID: 21310475. PMCID: PMC3085667
  16. Thadhani R, Appelbaum E, Chang Y, Pritchett Y, Bhan I, Agarwal R, Zoccali C, Wanner C, Lloyd-Jones D, Cannata J, Thompson T, Audhya P, Andress D, Zhang W, Ye J, Packham D, Singh B, Zehnder D, Manning WJ, Pachika A, Solomon SD. Vitamin D receptor activation and left ventricular hypertrophy in advanced kidney disease. Am J Nephrol. 2011;33(2):139-49. PMID: 21242674
  17. Camargo CA Jr, Ingham T, Wickens K, Thadhani R, Silvers KM, Epton MJ, Town GI, Pattemore PK, Espinola JA, Crane J; New Zealand Asthma and Allergy Cohort Study Group. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics. 2011;127(1):e180-7. PMID: 21187313
  18. Powe CE, Thadhani R. Diabetes and the kidney in pregnancy. Semin Nephrol. 2011;31(1):59-69. PMID: 21266265
2010
  1. Camargo CA, Ingham T, Wickens K, Thadhani RI, Silvers KM, Epton MJ, Town GI,Espinola JA, Crane J; the New Zealand Asthma and Allergy Cohort Study Group. Vitamin D status of newborns in New Zealand. Br J Nutr. 2010 Oct;104(7):1051-7. PMID: 20426893
  2. Powe CE, Seely EW, Rana S, Bhan I, Ecker J, Karumanchi SA, Thadhani R. First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia. Hypertension. 2010 Oct;56(4):758-63. Epub 2010 Aug 23. PMID: 20733087 PMCID: PMC3775612
  3. Afkarian M, Bhasin M, Dillon ST, Guerrero MC, Nelson RG, Knowler WC, Thadhani R, Libermann TA. Optimizing a proteomics platform for urine biomarker discovery. Mol Cell Proteomics. 2010 Oct;9(10):2195-204. PMID: 20511394 PMCID: PMC2957724
  4. Karumanchi SA, Thadhani R. A complement to kidney disease: CFHR5 nephropathy. Lancet. 2010;376(9743):748-50. PMID: 20800272
  5. Kong J, Kim GH, Wei M, Sun T, Li G, Liu SQ, Li X, Bhan I, Zhao Q, Thadhani R, Li YC. Therapeutic Effects of Vitamin D Analogs on Cardiac Hypertrophy in Spontaneously Hypertensive Rats. Am J Pathol. 2010 Aug;177(2):622-31. PMID: 20616348 PMCID: PMC2913045
  6. Bhan I, Hewison M, Thadhani R. Dietary vitamin D intake in advanced CKD/ESRD. Semin Dial. 2010 Jul-Aug;23(4):407-10. Review. PMID: 20701720
  7. Rucker D, Thadhani R, Tonelli M. Trace Element Status in Hemodialysis Patients. Semin Dial. 2010 Jul-Aug;23(4):389-95. PMID: 20557491.
  8. Rhee EP, Souza A, Farrell L, Pollak MR, Lewis GD, Steele DJ, Thadhani R, Clish CB, Greka A, Gerszten RE. Metabolite profiling identifies markers of uremia. J Am Soc Nephrol. 2010 Jun;21(6):1041-1051. PMID: 20378825 PMCID: PMC2900954
  9. Shurraw S, Majumdar SR, Thadhani R, Wiebe N, Tonelli M; Alberta Kidney Disease Network. Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis. Am J Kidney Dis. 2010 May;55(5):875-84. Epub 2010 Mar 25. PubMed PMID: 20346561.
  10. Chan KE, Thadhani R, Lazarus JM, Hakim RM. Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes. Clin J Am Soc Nephrol. 2010 May;5(5):856-66. Epub 2010 Mar 25. PubMed PMID: 20338963; PubMed Central PMCID: PMC2863967.
  11. Brunelli SM, Chertow GM, Ankers ED, Lowrie EG, Thadhani R. Shorter dialysis times are associated with higher mortality among incident hemodialysis patients. Kidney Int. 2010 Apr;77(7):630-6. Epub 2010 Jan 20. PubMed PMID: 20090666; PubMed Central PMCID: PMC2864594.
  12. Steinberg G, Lee C, Rauh-Hain JA, Ecker J, Khankin EV, Hsu CD, Cohen B, Rana S, Karumanchi SA, Thadhani R, Hacker MR, Lim KH. Early-pregnancy soluble Fas levels in idiopathic small-for-gestational-age pregnancies. Am J Obstet Gynecol. 2010 Mar;202(3):299.e1-7. PubMed PMID: 20207247.
  13. Bhan I, Burnett-Bowie SA, Ye J, Tonelli M, Thadhani R. Clinical measures identify vitamin D deficiency in dialysis. Clin J Am Soc Nephrol. 2010 Mar;5(3):460-7. Epub 2010 Feb 25. PubMed PMID: 20185603; PubMed Central PMCID: PMC2827576.
  14. Thadhani R, Powe CE, Tjoa ML, Khankin E, Ye J, Ecker J, Schneyer A, Karumanchi SA. First-trimester follistatin-like-3 levels in pregnancies complicated by subsequent gestational diabetes mellitus. Diabetes Care. 2010 Mar;33(3):664-9. Epub 2009 Dec 10. PubMed PMID: 20007937; PubMed Central PMCID: PMC2827528.
  15. Stuebe AM, McElrath TF, Thadhani R, Ecker JL. Second trimester insulin resistance, early pregnancy body mass index and gestational weight gain. Matern Child Health J. 2010 Mar;14(2):254-60. Epub 2009 Feb 5. PubMed PMID: 19194791.
  16. Khankin EV, Mutter WP, Tamez H, Yuan HT, Karumanchi SA, Thadhani R. Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease. PLoS One. 2010 Feb 16;5(2):e9246. PubMed PMID: 20169072; PubMed Central PMCID: PMC2821920.
  17. Thadhani R. Inching towards a targeted therapy for preeclampsia. Hypertension. 2010 Feb;55(2):238-40. Epub 2009 Dec 21. PubMed PMID: 20026761. PMCID: PMC4040955
  18. Testa A, Mallamaci F, Benedetto FA, Pisano A, Tripepi G, Malatino L, Thadhani R, Zoccali C. Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients. J Bone Miner Res. 2010 Feb;25(2):313-9. PubMed PMID: 20422622.
  19. Lee PS, Bhan I, Thadhani R. The potential role of plasma gelsolin in dialysis-related protein-energy wasting. Blood Purif. 2010;29(2):99-101. Epub 2010 Jan 8. Review. PubMed PMID: 20093811.
  20. Karumanchi SA, Thadhani R. Kidney complications: why don’t statins always work? Nat Med. 2010 Jan;16(1):38-40. Review. PubMed PMID: 20057425.
2009
  1. Knebelmann B, Kurschat C, Thadhani R. Enzyme therapy for Fabry’s disease: registered for success? Lancet. 2009 Dec 12;374(9706):1950-1. Epub . PubMed PMID: 19959220.
  2. Bhan I, Thadhani R. Vascular calcification and ESRD: a hard target. Clin J Am Soc Nephrol. 2009 Dec;4 Suppl S102-5. Review. PubMed PMID: 19995990.
  3. Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, Melamed ML, Wiebe N, Muntner P. Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation. 2009 Nov 3;120(18):1784-92. Epub 2009 Oct 19. PubMed PMID: 19841303.
  4. Thadhani R. Is calcitriol life-protective for patients with chronic kidney disease? J Am Soc Nephrol. 2009 Nov;20(11):2285-90. Epub 2009 Aug 13. PubMed PMID: 19679671.
  5. Friedman DJ, Afkarian M, Tamez H, Bhan I, Isakova T, Wolf M, Ankers E, Ye J, Tonelli M, Zoccali C, Kuro-o M, Moe O, Karumanchi SA, Thadhani R. Klotho variants and chronic hemodialysis mortality. J Bone Miner Res. 2009 Nov;24(11):1847-55. PubMed PMID: 19419323; PubMed Central PMCID: PMC2765930.
  6. Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, Chiu YW, Martins D, Adler SG, Norris KC. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 2009 Nov;76(9):977-83. Epub 2009 Aug 5. PubMed PMID: 19657329.
  7. Chan KE, Lazarus JM, Thadhani R, Hakim RM. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol. 2009 Oct;20(10):2223-33. Epub 2009 Aug 27. PubMed PMID: 19713308; PubMed Central PMCID: PMC2754104.
  8. Melamed ML, Thadhani R. Low calcidiol levels and coronary artery calcification: true, true, and related? J Am Soc Nephrol. 2009 Aug;20(8):1663-5. Epub 2009 Jul 16. PubMed PMID: 19608699.
  9. Block GA, Persky MS, Ketteler M, Kestenbaum B, Thadhani R, Kooienga L, Spiegel D, Asplin J, Ehrlich J, Dennis V, Nissenson A, Chertow GM, Wheeler DC. A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: a new paradigm for clinical outcomes studies in nephrology. Hemodial Int. 2009 Jul;13(3):360-2. Epub 2009 Jul 7. PubMed PMID: 19601992.
  10. Scragg R, Thadhani R, Camargo CA Jr. Association between altitude and mortality in incident dialysis patients. JAMA. 2009 Jun 17;301(23):2442-3; author reply 2443. PubMed PMID: 19531780.
  11. Tonelli M, Wiebe N, Hemmelgarn B, Klarenbach S, Field C, Manns B, Thadhani R, Gill J; Alberta Kidney Disease Network. Trace elements in hemodialysis patients: a systematic review and meta-analysis. BMC Med. 2009 May 19;25. Review. PubMed PMID: 19454005; PubMed Central PMCID: PMC2698829.
  12. Lee PS, Sampath K, Karumanchi SA, Tamez H, Bhan I, Isakova T, Gutierrez OM, Wolf M, Chang Y, Stossel TP, Thadhani R. Plasma gelsolin and circulating actin correlate with hemodialysis mortality. J Am Soc Nephrol. 2009 May;20(5):1140-8. Epub 2009 Apr 23. PubMed PMID: 19389844; PubMed Central PMCID: PMC2678046.
  13. Brunelli SM, Thadhani R, Ikizler TA, Feldman HI. Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes. Kidney Int. 2009 May;75(9):961-8. Epub 2009 Feb 4. PubMed PMID: 19190679; PubMed Central PMCID: PMC2864092.
  14. Chan KE, Lazarus JM, Thadhani R, Hakim RM. Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients. J Am Soc Nephrol. 2009 Apr;20(4):872-81. Epub 2009 Mar 18. PubMed PMID: 19297555; PubMed Central PMCID: PMC2663838.
  15. Rauh-Hain JA, Rana S, Tamez H, Wang A, Cohen B, Cohen A, Brown F, Ecker JL, Karumanchi SA, Thadhani R. Risk for developing gestational diabetes in women with twin pregnancies. J Matern Fetal Neonatal Med. 2009 Apr;22(4):293-9. PubMed PMID: 19340713.
  16. Gombart AF, Bhan I, Borregaard N, Tamez H, Camargo CA Jr, Koeffler HP, Thadhani R. Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clin Infect Dis. 2009 Feb 15;48(4):418-24. PubMed PMID: 19133797.
2008
  1. Isakova T, Gutierrez OM, Chang Y, Shah A, Tamez H, Smith K, Thadhani R, Wolf; M. Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol. 2009 Feb;20(2):388-96. Epub 2008 Dec 17. PMID: 19092121; PMCID: PMC2637053.
  2. Maynard SE, Thadhani R. Pregnancy and the kidney. J Am Soc Nephrol. 2009 Jan;20(1):14-22. Epub 2008 Dec 31. Review. PMID: 19118150.
  3. Bhan I, Thadhani R. Vitamin D therapy for chronic kidney disease. Semin Nephrol. 2009 Jan;29(1):85-93. Review. PMID: 19121478.
  4. Brunelli SM, Lynch KE, Ankers ED, Joffe MM, Yang W, Thadhani RI, Feldman HI.; Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients. Clin J Am Soc Nephrol. 2008 Nov;3(6):1733-40. Epub 2008 Oct 15. PMID: 18922985; PMCID: PMC2572293.
  5. Troisi R, Hoover RN, Thadhani R, Hsieh CC, Sluss P, Ballard-Barbash R, Potischman N. Maternal, prenatal and perinatal characteristics and first trimester maternal serum hormone concentrations. Br J Cancer. 2008 Oct 7;99(7):1161-4. PMID: 18766187; PMCID: PMC2567091.
  6. Brunelli SM, Thadhani RI, Lynch KE, Ankers ED, Joffe MM, Boston R, Chang Y, Feldman HI. Association between long-term blood pressure variability and mortality among incident hemodialysis patients. Am J Kidney Dis. 2008 Oct;52(4):716-26. PMID: 18752875.
  7. Thadhani R, Solomon CG. Preeclampsia–a glimpse into the future? N Engl J Med. 2008 Aug 21;359(8):858-60. PubMed PMID: 18716304.
  8. Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, Wolf M. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008 Aug 7;359(6):584-92. PMID: 18687639 PMCID: PMC2890264.
  9. Gutierrez OM, Tamez H, Bhan I, Zazra J, Tonelli M, Wolf M, Januzzi JL, Chang Y, Thadhani R. N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements. Clin Chem. 2008 Aug;54(8):1339-48. PMID: 18539645.
  10. Sidbury R, Sullivan AF, Thadhani RI, Camargo CA Jr. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol. 2008 Jul;159(1):245-7. PMID: 18489598.
  11. Wolf M, Betancourt J, Chang Y, Shah A, Teng M, Tamez H, Gutierrez O, Camargo CA Jr, Melamed M, Norris K, Stampfer MJ, Powe NR, Thadhani R. Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol. 2008 Jul;19(7):1379-88. PMID: 18400938; PMCID: PMC2440300.
  12. Thadhani R. Targeted ablation of the vitamin D 1alpha-hydroxylase gene: getting to the heart of the matter. Kidney Int. 2008 Jul;74(2):141-3. PMID: 18591942.
  13. Thadhani R. Activated vitamin D sterols in kidney disease. Lancet. 2008 Feb 16;371(9612):542-4. PMID: 18280316.
  14. Eskild A, Jeansson S, Jenum PA, Staff AC, Thadhani R, Karumanchi A, Vatten LJ. Levels of angiogenic factors in pregnancy and post-partum bleeding. Acta Obstet Gynecol Scand. 2008;87(10):1081-3. PMID: 18792843.
  15. Shaham O, Wei R, Wang TJ, Ricciardi C, Lewis GD, Vasan RS, Carr SA, Thadhani R, Gerszten RE, Mootha VK. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol. 2008;214. PMID: 18682704; PMCID: PMC2538910.
2007
  1. Bodyak N, Ayus JC, Achinger S, Shivalingappa V, Ke Q, Chen YS, Rigor DL, Stillman I, Tamez H, Kroeger PE, Wu-Wong RR, Karumanchi SA, Thadhani R, Kang PM. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16810-5. Epub 2007 Oct 17. PubMed PMID: 17942703; PubMed Central PMCID: PMC2040477.
  2. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007 Oct;72(8):1004-13. Epub 2007 Aug 8. PubMed PMID: 17687259.
  3. Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, Thadhani R. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension. 2007 Jul;50(1):137-42. Epub 2007 May 21. PubMed PMID: 17515455.
  4. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007 Jun 11;167(11):1159-65. PubMed PMID: 17563024.
  5. Smirnakis KV, Plati A, Wolf M, Thadhani R, Ecker JL. Predicting gestational diabetes: choosing the optimal early serum marker. Am J Obstet Gynecol. 2007 Apr;196(4):410.e1-6; discussion 410.e6-7. PubMed PMID: 17403439.
  6. Otu HH, Can H, Spentzos D, Nelson RG, Hanson RL, Looker HC, Knowler WC, Monroy M, Libermann TA, Karumanchi SA, Thadhani R. Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care. 2007 Mar;30(3):638-43. PubMed PMID: 17327333.
  7. Hubel CA, Wallukat G, Wolf M, Herse F, Rajakumar A, Roberts JM, Markovic N, Thadhani R, Luft FC, Dechend R. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension. 2007 Mar;49(3):612-7. Epub 2007 Jan 8. PubMed PMID: 17210828.
  8. Wolf M, Thadhani R. Vitamin D in patients with renal failure: a summary of observational mortality studies and steps moving forward. J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):487-90. Epub 2007 Jan 2. Review. PubMed PMID: 17197169; PubMed Central PMCID: PMC1865131.
  9. Thadhani R, Wolf M. Vitamin D in patients with kidney disease: cautiously optimistic. Adv Chronic Kidney Dis. 2007 Jan;14(1):22-6. Review. PubMed PMID: 17200040.
  10. Knickerbocker T, Chen JR, Thadhani R, MacBeath G. An integrated approach to prognosis using protein microarrays and nonparametric methods. Mol Syst Biol. 2007;123. Epub 2007 Jun 26. PubMed PMID: 17593911; PubMed Central PMCID: PMC1911205.
2006
2005
  1. Williams WW Jr, Ecker JL, Thadhani RI, Rahemtullah A. Case records of the Massachusetts General Hospital. Case 38-2005. A 29-year-old pregnant woman with the nephrotic syndrome and hypertension. N Engl J Med. 2005 Dec 15;353(24):2590-600. PubMed PMID: 16354896.
  2. Thadhani RI, Johnson RJ, Karumanchi SA. Hypertension during pregnancy: a disorder begging for pathophysiological support. Hypertension. 2005 Dec;46(6):1250-1. Epub 2005 Oct 24. Review. PubMed PMID: 16246974.
  3. Smirnakis KV, Chasan-Taber L, Wolf M, Markenson G, Ecker JL, Thadhani R. Postpartum diabetes screening in women with a history of gestational diabetes. Obstet Gynecol. 2005 Dec;106(6):1297-303. PubMed PMID: 16319255.
  4. Ayus JC, Mizani MR, Achinger SG, Thadhani R, Go AS, Lee S. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol. 2005 Sep;16(9):2778-88. Epub 2005 Jul 20. PubMed PMID: 16033855.
  5. Rajakumar A, Michael HM, Rajakumar PA, Shibata E, Hubel CA, Karumanchi SA, Thadhani R, Wolf M, Harger G, Markovic N. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta. 2005 Aug;26(7):563-73. PubMed PMID: 15993706.
  6. Wolf M, Shah A, Lam C, Martinez A, Smirnakis KV, Epstein FH, Taylor RN, Ecker JL, Karumanchi SA, Thadhani R. Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. Am J Obstet Gynecol. 2005 Jul;193(1):16-22. PubMed PMID: 16021053.
  7. Wolf M, Thadhani R. Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease. Semin Dial. 2005 Jul-Aug;18(4):302-6. Review. Erratum in: Semin Dial. 2007 Jan-Feb;20(1):table of contents. PubMed PMID: 16076353.
  8. Potischman N, Troisi R, Thadhani R, Hoover RN, Dodd K, Davis WW, Sluss PM, Hsieh CC, Ballard-Barbash R. Pregnancy hormone concentrations across ethnic groups: implications for later cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1514-20. PubMed PMID: 15941965.
  9. Smirnakis KV, Martinez A, Blatman KH, Wolf M, Ecker JL, Thadhani R. Early pregnancy insulin resistance and subsequent gestational diabetes mellitus. Diabetes Care. 2005 May;28(5):1207-8. PubMed PMID: 15855591.
  10. Maynard SE, Venkatesha S, Thadhani R, Karumanchi SA. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr Res. 2005 May;57(5 Pt 2):1R-7R. Epub 2005 Apr 6. Review. PubMed PMID: 15817508.
  11. Han WK, Alinani A, Wu CL, Michaelson D, Loda M, McGovern FJ, Thadhani R, Bonventre JV. Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. J Am Soc Nephrol. 2005 Apr;16(4):1126-34. Epub 2005 Mar 2. PubMed PMID: 15744000; PubMed Central PMCID: PMC1307501.
  12. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hern n MA, Camargo CA Jr, Thadhani R. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol. 2005 Apr;16(4):1115-25. Epub 2005 Feb 23. PubMed PMID: 15728786.
  13. Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, Blink AL, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Urinary placental growth factor and risk of preeclampsia. JAMA. 2005 Jan 5;293(1):77-85. PubMed PMID: 15632339.
  14. Wolf M, Hubel CA, Lam C, Sampson M, Ecker JL, Ness RB, Rajakumar A, Daftary A, Shakir AS, Seely EW, Roberts JM, Sukhatme VP, Karumanchi SA, Thadhani R. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab. 2004 Dec;89(12):6239-43. PubMed PMID: 15579783.
2004
  1. Thadhani R, Ecker JL, Mutter WP, Wolf M, Smirnakis KV, Sukhatme VP, Levine RJ, Karumanchi SA. Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia. Hypertension. 2004 May;43(5):988-92. Epub 2004 Mar 15. PubMed PMID: 15023932.
  2. Wolf M, Shah A, Jimenez-Kimble R, Sauk J, Ecker JL, Thadhani R. Differential risk of hypertensive disorders of pregnancy among Hispanic women. J Am Soc Nephrol. 2004 May;15(5):1330-8. PubMed PMID: 15100374.
  3. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004 Feb 12;350(7):672-83. Epub 2004 Feb 5. PubMed PMID: 14764923.
  4. Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J, Karumanchi SA. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab. 2004 Feb;89(2):770-5. PubMed PMID: 14764795.
  5. Tong AT, Roudaut R, Ozkan M, Sagie A, Shahid MS, Pontes J nior SC, Carreras F, Girard SE, Arnaout S, Stainback RF, Thadhani R, Zoghbi WA; Prosthetic Valve Thrombolysis-Role of Transesophageal Echocardiography (PRO-TEE) Registry Investigators. Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registry. J Am Coll Cardiol. 2004 Jan 7;43(1):77-84. PubMed PMID: 14715187.
  6. Wolf M, Sauk J, Shah A, Vossen Smirnakis K, Jimenez-Kimble R, Ecker JL, Thadhani R. Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus. Diabetes Care. 2004 Jan;27(1):21-7. PubMed PMID: 14693961.
  7. Dusso AS, Thadhani R, Slatopolsky E. Vitamin D receptor and analogs. Semin Nephrol. 2004 Jan;24(1):10-6. Review. PubMed PMID: 14730505.
2003
2002
  1. Wolf M, Sandler L, Jimenez-Kimble R, Shah A, Ecker JL, Thadhani R. Insulin resistance but not inflammation is associated with gestational hypertension. Hypertension. 2002 Dec;40(6):886-91. PubMed PMID: 12468574.
  2. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002 Jul;62(1):237-44. PubMed PMID: 12081583.
  3. Obrador GT, Ojo A, Thadhani R. End-stage renal disease in patients with Fabry disease. J Am Soc Nephrol. 2002 Jun;13 Suppl S144-6. Review. PubMed PMID: 12068027.
  4. Wolf M, Sandler L, Mu oz K, Hsu K, Ecker JL, Thadhani R. First trimester insulin resistance and subsequent preeclampsia: a prospective study. J Clin Endocrinol Metab. 2002 Apr;87(4):1563-8. PubMed PMID: 11932283.
  5. Bennett RL, Hart KA, O’Rourke E, Barranger JA, Johnson J, MacDermot KD, Pastores GM, Steiner RD, Thadhani R. Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors. J Genet Couns. 2002 Apr;11(2):121-46. PubMed PMID: 12735292.
  6. Thadhani R, Camargo CA Jr, Stampfer MJ, Curhan GC, Willett WC, Rimm EB. Prospective study of moderate alcohol consumption and risk of hypertension in young women. Arch Intern Med. 2002 Mar 11;162(5):569-74. PubMed PMID: 11871925.
  7. Pastores GM, Thadhani R. Advances in the management of Anderson-Fabry disease: enzyme replacement therapy. Expert Opin Biol Ther. 2002 Mar;2(3):325-33. Review. PubMed PMID: 11890871.
  8. Thadhani R, Wolf M, West ML, Tonelli M, Ruthazer R, Pastores GM, Obrador GT. Patients with Fabry disease on dialysis in the United States. Kidney Int. 2002 Jan;61(1):249-55. PubMed PMID: 11786107.
2001
1991-2000
  1. Thadhani R, Stampfer MJ, Hunter DJ, Manson JE, Solomon CG, Curhan GC. High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy. Obstet Gynecol. 1999 Oct;94(4):543-50. PubMed PMID: 10511356.0
  2. Thadhani R, Stampfer MJ, Chasan-Taber L, Willett WC, Curhan GC. A prospective study of pregravid oral contraceptive use and risk of hypertensive disorders of pregnancy. Contraception. 1999 Sep;60(3):145-50. PubMed PMID: 10640157.0
  3. Vonderheide RH, Thadhani R, Kuter DJ. Association of thrombocytopenia with the use of intra-aortic balloon pumps. Am J Med. 1998 Jul;105(1):27-32. PubMed PMID: 9688018.0
  4. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998 Mar 19;338(12):777-83. PubMed PMID: 9504937.0
  5. Pascual M, Thadhani R, Laposata M, Williams WW, Farrell ML, Johnson SM, Tolkoff-Rubin N, Cosimi AB. Anticardiolipin antibodies and hepatic artery thrombosis after liver transplantation. Transplantation. 1997 Nov 15;64(9):1361-4. PubMed PMID: 9371681.0
  6. Pascual M, Thadhani R, Chung RT, Williams WW Jr, Meehan S, Tolkoff-Rubin N, Colvin R, Cosimi AB. Nephrotic syndrome after liver transplantation in a patient with hepatitis C virus-associated glomerulonephritis. Transplantation. 1997 Oct 15;64(7):1073-6. PubMed PMID: 9381532.0
  7. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med. 1996 May 30;334(22):1448-60. Review. PubMed PMID: 8618585.0
  8. Thadhani R, Pascual M, Nickeleit V, Tolkoff-Rubin N, Colvin R. Preliminary description of focal segmental glomerulosclerosis in patients with renovascular disease. Lancet. 1996 Jan 27;347(8996):231-3. PubMed PMID: 8551883.0
  9. Thadhani RI, Camargo CA Jr, Xavier RJ, Fang LS, Bazari H. Atheroembolic renal failure after invasive procedures. Natural history based on 52 histologically proven cases. Medicine (Baltimore). 1995 Nov;74(6):350-8. PubMed PMID: 7500898.0
  10. Hsu SI, Thadhani RI, Daniels GH. Acute compartment syndrome in a hypothyroid patient. Thyroid. 1995 Aug;5(4):305-8. PubMed PMID: 7488873.1
  11. Lee AH, Chin AE, Ramanujam T, Thadhani RI, Callegari PE, Freundlich B. Gonococcal septic arthritis of the hip. J Rheumatol. 1991 Dec;18(12):1932-3. PubMed PMID: 1795336.1